https://curecurrent.com/trials/matrix-metalloproteinases-and-diabetic-nephropathy-6412 https://curecurrent.com/trials/efficacy-and-safety-of-tak-875-in-subjects-with-type-2-diabetes-mellitus-6413 https://curecurrent.com/trials/effect-of-exenatide-treatment-on-liver-fat-content-in-patients-with-diabetes-6414 https://curecurrent.com/trials/improving-diabetes-care-collaboratively-in-the-community-6415 https://curecurrent.com/trials/early-feasibility-study-of-zone-mpc-and-hms-with-dias-in-the-outpatient-setting-6416 https://curecurrent.com/trials/chromium-and-insulin-action-6417 https://curecurrent.com/trials/assessing-the-effectiveness-of-a-weight-watchers-based-lifestyle-intervention-for-the-primary-prevention-of-type-2-diabe-6418 https://curecurrent.com/trials/effect-of-chromium-picolinate-on-insulin-sensitivity-in-type-2-diabetes-6419 https://curecurrent.com/trials/a-study-evaluating-safety-and-efficacy-of-biod-531-compared-to-humalog-mix-75-25-in-subjects-with-type-2-diabetes-6420 https://curecurrent.com/trials/lea29y-belatacept-emory-edmonton-protocol-6421 https://curecurrent.com/trials/healthy-lifestyles-for-mentally-ill-people-who-have-experienced-weight-gain-from-their-antipsychotic-medications-6422 https://curecurrent.com/trials/exposure-to-type-ii-diabetes-for-two-siblings-with-the-same-parents-6423 https://curecurrent.com/trials/comparison-of-tak-875-fasiglifam-with-placebo-in-participants-with-type-2-diabetes-6424 https://curecurrent.com/trials/linagliptin-as-add-on-therapy-to-empagliflozin-10-mg-or-25-mg-with-background-metformin-in-patient-with-type-2-diabetes-6425 https://curecurrent.com/trials/efficacy-and-safety-of-tak-875-in-combination-with-sitagliptin-in-participants-with-type-2-diabetes-mellitus-6426 https://curecurrent.com/trials/the-effectiveness-of-resistance-training-on-glycemic-control-for-patients-with-type-2-diabetes-in-cardiac-rehabilitation-6427 https://curecurrent.com/trials/mechanisms-of-glycemic-improvement-after-gastrointestinal-surgery-6428 https://curecurrent.com/trials/calorie-reduction-or-surgery-seeking-remission-for-obesity-and-diabetes-6429 https://curecurrent.com/trials/a-study-of-the-impact-of-genetic-testing-on-clinical-decision-making-and-patient-care-6430 https://curecurrent.com/trials/effect-of-formoterol-on-the-counterregulatory-hormonal-response-to-hypoglycemia-in-type-1-diabetes-6431 https://curecurrent.com/trials/reproducibility-and-method-comparison-studies-of-the-quo-test-a1c-system-and-the-quo-lab-a1c-test-and-clia-waiver-study-6432 https://curecurrent.com/trials/physiologic-response-to-glucagon-at-varying-insulin-levels-6433 https://curecurrent.com/trials/a-study-of-insulin-peglispro-ly2605541-in-participants-with-type-2-diabetes-mellitus-6434 https://curecurrent.com/trials/patient-and-provider-glucose-reporting-preferences-ambulatory-glucose-profile-agp-6435 https://curecurrent.com/trials/b-lymphocyte-immunotherapy-in-islet-transplantation-6436 https://curecurrent.com/trials/walnut-consumption-endothelial-function-and-biomarkers-6437 https://curecurrent.com/trials/apt001-plasma-no-generator-to-treat-diabetic-foot-ulcer-in-adults-6438 https://curecurrent.com/trials/peritransplant-deoxyspergualin-in-islet-transplantation-in-type-1-diabetes-6439 https://curecurrent.com/trials/the-effectiveness-of-lubiprostone-in-constipated-diabetics-6440 https://curecurrent.com/trials/pharmacodynamic-evaluation-of-pl2200-versus-enteric-coated-and-immediate-release-aspirin-in-diabetic-patients-6441 https://curecurrent.com/trials/implementation-of-a-patient-centered-self-management-program-for-patients-with-type-2-diabetes-6442 https://curecurrent.com/trials/pharmacodynamic-evaluation-of-pl2200-versus-enteric-coated-aspirin-in-diabetic-patients-6443 https://curecurrent.com/trials/pyridorin-in-diabetic-nephropathy-6444 https://curecurrent.com/trials/the-comparative-effectiveness-of-telemedicine-to-detect-diabetic-retinopathy-6445 https://curecurrent.com/trials/adjunctive-metformin-therapy-in-double-diabetes-6446 https://curecurrent.com/trials/study-to-compare-single-dose-of-three-modified-release-formulations-of-pf-04937319-with-immediate-release-material-spari-6447 https://curecurrent.com/trials/a-randomized-comparison-of-amnioclear-human-allograft-amniotic-membrane-vs-moist-wound-dressing-in-the-treatment-of-diab-6448 https://curecurrent.com/trials/long-term-effects-of-diabetes-of-very-young-children-6449 https://curecurrent.com/trials/glucose-meter-study-6450 https://curecurrent.com/trials/performance-evaluation-of-an-investigational-blood-glucose-monitoring-system-6451 https://curecurrent.com/trials/evaluation-of-labeling-comprehension-and-performance-of-a-new-blood-glucose-meter-system-6452 https://curecurrent.com/trials/user-performance-evaluation-of-an-investigational-blood-glucose-monitoring-system-6453 https://curecurrent.com/trials/evaluation-of-an-karajishi-contour-investigational-blood-glucose-monitoring-system-6454 https://curecurrent.com/trials/comparison-evaluation-of-blood-glucose-meter-systems-in-a-clinical-setting-6455 https://curecurrent.com/trials/evaluation-of-a-diabetes-data-management-system-6456 https://curecurrent.com/trials/in-clinic-and-home-use-study-of-a-new-blood-glucose-monitoring-system-6457 https://curecurrent.com/trials/evaluation-of-glucofacts-deluxe-diabetes-management-system-6458 https://curecurrent.com/trials/study-of-an-investigational-glucose-meter-system-6459 https://curecurrent.com/trials/evaluation-of-an-karajishi-ts-investigational-blood-glucose-monitoring-system-6460 https://curecurrent.com/trials/study-of-an-investigational-glucose-meter-system-6461 https://curecurrent.com/trials/comparison-evaluation-of-blood-glucose-meter-systems-6462 https://curecurrent.com/trials/evaluation-of-blood-glucose-meter-systems-6463 https://curecurrent.com/trials/performance-of-an-investigational-blood-glucose-monitoring-system-6464 https://curecurrent.com/trials/evaluation-of-a-new-blood-glucose-meter-system-with-capillary-and-venous-blood-6465 https://curecurrent.com/trials/evaluation-of-blood-glucose-monitoring-systems-6466 https://curecurrent.com/trials/user-study-of-an-investigational-blood-glucose-monitoring-system-6467 https://curecurrent.com/trials/performance-of-a-new-glucose-meter-system-in-children-and-young-adults-6468 https://curecurrent.com/trials/evaluation-of-the-a1cnow-test-kit-6469 https://curecurrent.com/trials/performance-evaluation-of-blood-glucose-monitoring-system-using-iso-study-design-6470 https://curecurrent.com/trials/performance-of-an-investigational-blood-glucose-monitoring-system-in-a-clinical-trial-6471 https://curecurrent.com/trials/performance-of-a-new-glucose-meter-system-6472 https://curecurrent.com/trials/performance-of-an-investigational-blood-glucose-monitoring-system-in-a-clinical-setting-6473 https://curecurrent.com/trials/evaluation-of-an-karajishi-contour-investigational-blood-glucose-monitoring-system-iso-fda-study-6474 https://curecurrent.com/trials/the-health-outcomes-management-and-evaluation-home-study-6475 https://curecurrent.com/trials/reducing-risk-of-type-2-diabetes-hydroxychloroquine-use-in-pre-diabetes-6476 https://curecurrent.com/trials/12-week-efficacy-and-safety-study-of-empagliflozin-bi-10773-in-hypertensive-patients-with-type-2-diabetes-mellitus-6477 https://curecurrent.com/trials/safety-and-efficacy-study-of-empagliflozin-and-metformin-for-24-weeks-in-treatment-naive-patients-with-type-2-diabetes-6478 https://curecurrent.com/trials/develop-and-validate-a-self-administered-instrument-that-will-screen-for-eating-disorder-symptoms-in-persons-aged-12-and-6479 https://curecurrent.com/trials/personalized-decision-support-for-older-patients-with-diabetes-6480 https://curecurrent.com/trials/evaluating-electrocardiogram-ecg-abnormalities-from-young-adulthood-through-middle-age-6481 https://curecurrent.com/trials/effect-of-naltrexone-on-counterregulatory-mechanisms-in-hypoglycemia-6482 https://curecurrent.com/trials/a-trial-comparing-the-efficacy-of-insulin-degludec-with-insulin-glargine-on-glycaemic-control-using-continuous-glucose-m-6483 https://curecurrent.com/trials/modulation-of-human-myocardial-metabolism-by-glp-1-dose-response-6484 https://curecurrent.com/trials/drug-drug-interaction-study-of-glucokinase-activator-hms5552-and-metformin-in-t2dm-6485 https://curecurrent.com/trials/santyl-applications-to-diabetic-foot-ulcers-6486 https://curecurrent.com/trials/study-of-secukinumab-in-patients-with-newly-diagnosed-type-1-diabetes-mellitus-6487 https://curecurrent.com/trials/autologous-dendritic-cell-therapy-for-type-1-diabetes-suppression-a-safety-study-6488 https://curecurrent.com/trials/effects-of-stevia-on-satiety-and-eating-attitudes-in-healthy-overweight-and-obese-adults-6489 https://curecurrent.com/trials/caloric-restriction-exercise-and-glucoregulation-in-humans-6490 https://curecurrent.com/trials/phase-1-study-of-anti-glycation-agent-gly-230-in-healthy-subjects-6491 https://curecurrent.com/trials/immunosuppressive-medications-for-participants-in-itn005ct-nct00014911-6492 https://curecurrent.com/trials/biod-531-vs-humalog-mix-75-25-vs-humulin-r-u-500-post-meal-glucose-control-in-patients-with-severe-insulin-resistance-6493 https://curecurrent.com/trials/comparison-of-postprandial-glucose-control-associated-with-biod-531-vs-humalog-mix-75-25-vs-humulin-r-u-500-6494 https://curecurrent.com/trials/impact-of-fluid-milk-on-post-meal-glycemia-and-insulinemia-in-overwt-obese-adults-6495 https://curecurrent.com/trials/safety-study-to-lower-the-risk-of-heart-failure-is-also-effective-in-reducing-stiffness-of-the-arteries-6496 https://curecurrent.com/trials/a-pilot-study-of-hemin-therapy-for-gastroparesis-diabetes-mellitus-6497 https://curecurrent.com/trials/gestational-diabetes-diagnostic-methods-6498 https://curecurrent.com/trials/a-feasibility-study-to-assess-critical-aspects-of-fluorescence-affinity-sensor-fas-performance-and-safety-over-several-h-6499 https://curecurrent.com/trials/effects-of-pioglitazone-on-platelet-function-6500 https://curecurrent.com/trials/effects-of-pulsed-intravenous-iv-insulin-on-brittle-and-uncontrolled-diabetes-6501 https://curecurrent.com/trials/a-pilot-study-of-switching-from-one-pain-medication-to-another-opioid-rotation-6502 https://curecurrent.com/trials/grafixcore-open-label-study-to-evaluate-the-safety-and-efficacy-of-grafixcore-for-complex-diabetic-foot-wounds-6503 https://curecurrent.com/trials/impact-of-decision-aids-to-enhance-shared-decision-making-for-diabetes-6504 https://curecurrent.com/trials/endotoxin-and-intestinal-flora-before-and-after-gastric-bypass-or-banding-in-diabetics-6505 https://curecurrent.com/trials/md2me-texting-to-promote-chronic-disease-management-6506 https://curecurrent.com/trials/genetics-of-peripheral-artery-genomics-6507 https://curecurrent.com/trials/advanced-comprehensive-diabetes-care-for-veterans-with-poorly-controlled-diabetes-6508 https://curecurrent.com/trials/a-portion-controlled-diet-will-prevent-weight-gain-in-diabetics-treated-with-actos-6509 https://curecurrent.com/trials/study-of-how-dulaglutide-compares-to-placebo-in-participants-with-type-2-diabetes-who-are-also-on-sulfonylurea-therapy-a-6510 https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-lipid-infusion-on-toll-like-receptor-4-tlr4-signaling-6511 https://curecurrent.com/trials/healthy-transitions-menopause-effect-on-obesity-energy-balance-and-insulin-6512 https://curecurrent.com/trials/switching-from-insulin-glargine-to-insulin-degludec-in-subjects-with-type-2-diabetes-mellitus-begin-6513 https://curecurrent.com/trials/text-messaging-for-weight-loss-6514 https://curecurrent.com/trials/empowering-rural-african-american-women-and-communities-to-improve-diabetes-outcomes-6515 https://curecurrent.com/trials/patient-transitioning-from-exubera-inhalation-powder-to-technosphere-insulin-inhalation-powder-6516 https://curecurrent.com/trials/comparing-diabetes-prevention-programs-6517 https://curecurrent.com/trials/the-effect-of-type-1-diabetes-on-pan-arterial-vascular-function-and-insulin-sensitivity-in-humans-6518 https://curecurrent.com/trials/recent-gdm-lifestyle-intervention-6519 https://curecurrent.com/trials/synchronization-to-improve-non-adherence-to-cardiovascular-medications-6520 https://curecurrent.com/trials/the-medication-metronome-project-study-to-facilitate-follow-up-testing-resulting-from-prescribed-medications-to-improve-6521 https://curecurrent.com/trials/effect-of-pioglitazone-on-timp-3-and-tace-in-type-2-diabetes-6522 https://curecurrent.com/trials/robust-evaluation-to-measure-improvements-in-nonadherence-from-low-cost-devices-6523 https://curecurrent.com/trials/prevention-of-self-care-deterioration-in-early-adolescents-with-diabetes-6524 https://curecurrent.com/trials/teens-connect-preventive-psycho-education-for-transitioning-teens-with-diabetes-6525 https://curecurrent.com/trials/natural-language-processing-and-quality-assessment-in-primary-care-6526 https://curecurrent.com/trials/text-message-reminders-to-increase-rates-of-postpartum-diabetes-screening-in-women-with-gestational-diabetes-6527 https://curecurrent.com/trials/a-pilot-study-of-the-provant-therapy-system-in-subjects-with-diabetic-foot-ulcers-6528 https://curecurrent.com/trials/mobile-phone-based-intervention-for-promoting-healthy-habits-and-weight-loss-6529 https://curecurrent.com/trials/diabetes-lipoproteins-and-accelerated-vascular-disease-6530 https://curecurrent.com/trials/the-effect-of-synching-prescription-refills-on-adherence-6531 https://curecurrent.com/trials/effect-of-fenugreek-on-blood-sugar-and-insulin-in-diabetic-humans-6532 https://curecurrent.com/trials/prediabetes-prehypertension-and-vitamin-d-supplementation-a-practice-based-clinical-intervention-pilot-study-6533 https://curecurrent.com/trials/take-time-pioglitazone-reverses-defects-in-mitochondrial-biogenesis-in-patients-with-t2dm-6534 https://curecurrent.com/trials/motivational-interviewing-and-cognitive-behavioral-therapy-based-intervention-for-cardiovascular-disease-prevention-amon-6535 https://curecurrent.com/trials/inpatient-self-monitoring-and-administration-study-ismas-6536 https://curecurrent.com/trials/insulin-resistance-before-and-during-pregnancy-in-women-with-polycystic-ovary-syndrome-6537 https://curecurrent.com/trials/regadenoson-blood-flow-in-type-1-diabetes-rabit1d-6538 https://curecurrent.com/trials/regulation-of-arginine-vasopressin-avp-6539 https://curecurrent.com/trials/take-charge-of-your-diabetes-6540 https://curecurrent.com/trials/evaluation-of-curexcell-in-treating-lower-extremity-chronic-ulcers-in-adults-with-diabetes-6541 https://curecurrent.com/trials/phase-2b-multicenter-randomized-double-blind-placebo-and-active-controlled-parallel-group-study-to-assess-the-pd-respons-6542 https://curecurrent.com/trials/the-ibep-study-an-intervention-for-lifestyle-modification-in-women-with-gestational-diabetes-6543 https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-in-subjects-with-type-2-diabetes-taking-twice-daily-exenatide-or-once-weekly-exenatide-6544 https://curecurrent.com/trials/clinical-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-pks-of-zydpla1-following-oral-administration-in-6545 https://curecurrent.com/trials/impact-of-self-monitoring-blood-glucose-frequency-on-glycemic-control-in-patients-with-type-2-diabetes-6546 https://curecurrent.com/trials/establishing-ambulatory-glucose-profiles-for-people-without-diabetes-using-cgm-data-6547 https://curecurrent.com/trials/develop-novel-methods-to-display-report-and-analyze-cgm-data-for-clinical-decision-making-in-people-with-diabetes-6548 https://curecurrent.com/trials/use-of-continuous-glucose-monitoring-combined-with-ambulatory-glucose-profiles-to-characterize-glycemic-control-6549 https://curecurrent.com/trials/training-doctors-to-support-patient-self-care-of-depression-6550 https://curecurrent.com/trials/characteristics-of-persons-with-an-eating-disorder-and-type-1-diabetes-6551 https://curecurrent.com/trials/the-impact-of-food-on-blood-sugar-in-people-with-type-2-diabetes-6552 https://curecurrent.com/trials/impact-of-periodontal-disease-on-outcomes-in-diabetes-6553 https://curecurrent.com/trials/support-group-surveys-for-individuals-who-have-type-1-diabetes-and-an-eating-disorder-6554 https://curecurrent.com/trials/using-continuous-glucose-monitoring-to-understand-the-glycemic-impact-of-food-6555 https://curecurrent.com/trials/the-empathy-toolkit-helping-diabetes-patients-overcome-barriers-to-medication-adherence-6556 https://curecurrent.com/trials/impact-of-continuing-medical-education-cme-insulin-program-6557 https://curecurrent.com/trials/glycemic-effect-of-colesevelam-hcl-welchol-in-patients-with-type-2-diabetes-6558 https://curecurrent.com/trials/observational-study-of-interstitial-glucose-monitoring-with-continuous-glucose-monitoring-to-track-patients-treated-with-6559 https://curecurrent.com/trials/type-1-diabetes-and-eating-disorder-diurnal-glucose-patterns-6560 https://curecurrent.com/trials/evaluation-of-glucose-monitoring-methods-characterizing-glycemic-control-in-subjects-with-diabetes-6561 https://curecurrent.com/trials/continuous-glucose-monitoring-self-monitored-blood-glucose-type-2-therapy-matrix-definition-6562 https://curecurrent.com/trials/assessment-of-non-fasting-vs-fasting-lipid-measures-in-diabetes-patients-6563 https://curecurrent.com/trials/modal-day-analysis-of-self-monitoring-blood-glucose-versus-continuous-glucose-monitoring-6564 https://curecurrent.com/trials/barriers-to-the-implementation-of-complete-insulin-order-sets-6565 https://curecurrent.com/trials/the-use-of-a-computer-program-to-help-primary-care-providers-treat-patients-with-type-2-diabetes-6566 https://curecurrent.com/trials/fat-induced-insulin-resistance-and-atherosclerosis-6567 https://curecurrent.com/trials/glycemic-response-to-oral-nutrition-supplements-6568 https://curecurrent.com/trials/medication-adherence-with-polyglot-meducation-6569 https://curecurrent.com/trials/a-pilot-study-of-metabolic-effects-of-omentectomy-6570 https://curecurrent.com/trials/estimation-of-malignancy-rates-within-humedica-patient-populations-sampled-to-be-representative-of-liraglutide-initiator-6571 https://curecurrent.com/trials/pilot-study-cardiovascular-events-in-high-risk-orthopedic-surgical-patients-6572 https://curecurrent.com/trials/effects-of-qigong-on-type-2-diabetic-patients-6573 https://curecurrent.com/trials/quantitative-18f-av-133-pet-imaging-in-subjects-with-diabetes-and-healthy-controls-6574 https://curecurrent.com/trials/multiple-ascending-dose-study-in-subjects-with-type-2-diabetes-6575 https://curecurrent.com/trials/a-comparative-efficacy-study-of-dermapure-to-treat-diabetic-foot-ulcers-6576 https://curecurrent.com/trials/risk-factors-for-implant-bone-loss-in-patients-with-diabetes-mellitus-6577 https://curecurrent.com/trials/pharmacogenetics-of-ace-inhibitor-associated-angioedema-6578 https://curecurrent.com/trials/diabetes-technology-study-of-real-time-glucose-alerts-in-the-team-management-of-diabetes-6579 https://curecurrent.com/trials/translating-a-heart-disease-lifestyle-intervention-into-the-community-6580 https://curecurrent.com/trials/retinal-blood-flow-and-microthrombi-in-type-1-diabetes-6581 https://curecurrent.com/trials/safety-and-efficacy-study-of-pyridorin-in-patients-with-nephropathy-due-to-type-2-diabetes-6582 https://curecurrent.com/trials/prevalence-of-inpatient-hyperglycemia-risks-complications-and-outcomes-6583 https://curecurrent.com/trials/increasing-medication-adherence-through-physician-incentives-and-messaging-6584 https://curecurrent.com/trials/continuous-glucose-monitoring-to-measure-effect-of-glycemic-index-6585 https://curecurrent.com/trials/moderate-to-vigorous-physical-activity-for-glycemic-control-in-patients-with-gestational-diabetes-mellitus-6586 https://curecurrent.com/trials/crossover-feasibility-study-of-portable-ap-device-with-zone-mpc-and-hms-and-adapted-i-c-and-basal-insulin-6587 https://curecurrent.com/trials/a-phase-2-multi-center-study-to-evaluate-the-efficacy-and-safety-of-a-chemokine-ccr2-5-receptor-antagonist-in-adults-wit-6588 https://curecurrent.com/trials/a-phase-iii-study-of-bms-512148-dapagliflozin-in-patients-with-type-2-diabetes-who-are-not-well-controlled-with-diet-and-6589 https://curecurrent.com/trials/a-phase-iii-study-of-bms-512148-dapagliflozin-in-patients-with-type-2-diabetes-who-are-not-well-controlled-on-metformin-6590 https://curecurrent.com/trials/evidence-based-amputee-rehabilitation-ebar-program-6591 https://curecurrent.com/trials/practice-based-nutrition-intervention-2-6592 https://curecurrent.com/trials/comparison-of-two-pharmacist-led-population-management-approaches-to-increase-monitoring-of-vitamin-b12-and-serum-creati-6593 https://curecurrent.com/trials/study-of-tak-875-in-adults-with-type-2-diabetes-and-cardiovascular-disease-or-risk-factors-for-cardiovascular-disease-6594 https://curecurrent.com/trials/regulation-of-branched-chain-amino-acid-metabolism-in-pre-diabetes-6595 https://curecurrent.com/trials/breakfast-nutrition-and-inpatient-glycemia-6596 https://curecurrent.com/trials/trial-of-an-herb-and-mineral-combination-product-on-fasting-glucose-in-adults-at-risk-for-developing-diabetes-6597 https://curecurrent.com/trials/examining-the-effects-of-diet-on-health-with-an-online-program-6598 https://curecurrent.com/trials/effect-of-discontinuation-of-sugar-sweetened-beverages-6599 https://curecurrent.com/trials/safety-study-of-bms-823778-in-subjects-with-type-2-diabetes-6600 https://curecurrent.com/trials/safety-study-of-bms-770767-in-subjects-with-type-2-diabetes-6601 https://curecurrent.com/trials/mobile-insulin-titration-intervention-6602 https://curecurrent.com/trials/diabetes-prevention-program-pilot-study-6603 https://curecurrent.com/trials/a-pilot-study-to-determine-the-safety-of-campath-1h-anti-cd52-antibody-therapy-in-newly-diagnosed-subjects-with-type-1-d-6604 https://curecurrent.com/trials/a-brief-intervention-to-improve-medication-knowledge-and-adherence-among-family-medicine-patients-in-south-texas-6605 https://curecurrent.com/trials/interprofessional-training-to-improve-diabetes-care-the-respect-trial-6606 https://curecurrent.com/trials/oral-and-non-insulin-injected-hypoglycemic-therapy-utilization-patterns-6607 https://curecurrent.com/trials/teamcare-for-diabetes-in-mental-health-centers-6608 https://curecurrent.com/trials/effectiveness-and-safety-study-of-the-dexcom-g4-continuous-glucose-monitoring-system-6609 https://curecurrent.com/trials/gastric-sleeve-pilot-study-in-morbidly-obese-undergoing-liver-transplantation-6610 https://curecurrent.com/trials/improving-prevention-of-heart-disease-in-latinos-6611 https://curecurrent.com/trials/free-test-strips-and-blood-glucose-control-6612 https://curecurrent.com/trials/evaluation-of-programs-of-coordinated-care-and-disease-management-6613 https://curecurrent.com/trials/laser-therapy-for-diabetic-peripheral-neuropathic-pain-6614 https://curecurrent.com/trials/comparison-of-fasiglifam-tak-875-with-sitagliptin-when-used-in-combination-with-metformin-in-patients-with-type-2-diabet-6615 https://curecurrent.com/trials/comparison-of-two-nn1250-formulations-in-healthy-volunteers-6616 https://curecurrent.com/trials/a-comparison-between-two-formulations-of-nn5401-in-healthy-subjects-6617 https://curecurrent.com/trials/effect-of-a-high-protein-diet-and-or-high-intensity-training-on-metabolic-syndrome-6618 https://curecurrent.com/trials/improving-diabetes-outcomes-through-lifestyle-change-idolc-study-6619 https://curecurrent.com/trials/blood-flow-responses-to-an-oral-glucose-tolerance-test-in-type-2-diabetes-6620 https://curecurrent.com/trials/an-observational-study-to-assess-longitudinal-variation-of-immune-biomarkers-in-subjects-at-risk-for-development-of-type-6621 https://curecurrent.com/trials/evaluation-of-the-bioavailability-of-pramlintide-6622 https://curecurrent.com/trials/evaluation-of-dose-titration-of-pramlintide-during-initiation-of-therapy-in-patients-trying-to-improve-glucose-control-6623 https://curecurrent.com/trials/using-patient-feedback-to-improve-communication-regarding-glycemic-control-to-patients-with-diabetes-6624 https://curecurrent.com/trials/study-of-the-long-term-safety-of-pramlintide-in-subjects-with-type-1-diabetes-mellitus-6625 https://curecurrent.com/trials/study-of-human-regular-u-500-insulin-in-adult-participants-with-type-2-diabetes-6626 https://curecurrent.com/trials/a-study-to-examine-the-pharmacokinetics-tolerability-safety-and-efficacy-of-exenatide-once-weekly-suspension-6627 https://curecurrent.com/trials/controlling-disease-using-inexpensive-it-hypertension-in-diabetes-6628 https://curecurrent.com/trials/mechanisms-of-diabetes-control-after-weight-loss-surgery-sub-study-1-6629 https://curecurrent.com/trials/very-low-calorie-diet-for-diabetic-kidney-disease-6630 https://curecurrent.com/trials/effectiveness-of-manual-manipulation-with-epat-on-ankle-dorsiflexion-and-dynamic-plantar-pressure-6631 https://curecurrent.com/trials/effects-of-exenatide-long-acting-release-on-glucose-control-and-safety-in-subjects-with-type-2-diabetes-mellitus-duratio-6632 https://curecurrent.com/trials/a-study-to-compare-the-effects-of-exenatide-and-sitagliptin-on-postprandial-glucose-in-subjects-with-type-2-diabetes-mel-6633 https://curecurrent.com/trials/challenging-the-gold-standard-pilot-study-comparing-continuous-glucose-monitoring-system-cgms-capillary-glucose-monitors-6634 https://curecurrent.com/trials/pilot-study-of-exenatide-pharmacokinetics-and-pharmacodynamics-in-gestational-diabetes-6635 https://curecurrent.com/trials/veterans-walk-for-health-study-6636 https://curecurrent.com/trials/a-study-to-examine-the-efficacy-safety-and-tolerability-and-pharmacokinetics-of-exenatide-once-monthly-suspension-6637 https://curecurrent.com/trials/comparison-study-of-the-glycemic-effects-safety-and-tolerability-of-exenatide-once-weekly-suspension-to-sitagliptin-and-6638 https://curecurrent.com/trials/study-on-the-impact-of-patient-navigators-on-the-health-education-and-quality-of-life-in-formerly-incarcerated-patients-6639 https://curecurrent.com/trials/a-study-to-evaluate-itca-650-for-the-treatment-of-type-2-diabetes-6640 https://curecurrent.com/trials/comparative-study-of-amniotic-membrane-wound-graft-in-the-management-of-diabetic-foot-ulcers-6641 https://curecurrent.com/trials/improved-glycemic-control-in-adult-subjects-with-type-1-diabetes-on-mdi-using-insulin-guidance-software-6642 https://curecurrent.com/trials/a-transgenerational-e-intervention-for-gestational-diabetics-and-their-offspring-6643 https://curecurrent.com/trials/postpartum-diabetes-screening-in-women-with-gestational-diabetes-6644 https://curecurrent.com/trials/effect-of-testosterone-gel-replacement-on-fat-mass-in-males-with-low-testosterone-levels-and-diabetes-6645 https://curecurrent.com/trials/validation-of-a-patient-decision-aid-for-type-2-diabetes-6646 https://curecurrent.com/trials/length-of-effect-of-extended-release-aspirin-on-platelets-in-patients-with-diabetes-and-heart-disease-6647 https://curecurrent.com/trials/e-pharmacovigilance-ii-surveillance-for-safety-and-effectiveness-calling-for-earlier-detection-of-adverse-reactions-6648 https://curecurrent.com/trials/to-evaluate-the-effect-on-post-prandial-glycemia-safety-and-tolerability-of-viaject-7-vs-lispro-insulin-during-subcutane-6649 https://curecurrent.com/trials/a-clinical-study-of-the-performance-of-a-glucose-blinding-protein-based-continuous-glucose-monitor-gbp-cgm-6650 https://curecurrent.com/trials/antioxidant-effects-of-pomegranate-juice-versus-placebo-in-adults-with-type-2-diabetes-mellitus-6651 https://curecurrent.com/trials/dka-optic-ultrasound-6652 https://curecurrent.com/trials/dietary-interventions-in-prediabetes-6653 https://curecurrent.com/trials/a-study-comparing-the-pharmacodynamic-properties-of-insulin-viaject-regular-human-insulin-and-insulin-lispro-6654 https://curecurrent.com/trials/depression-diabetes-mechanisms-urban-african-americans-6655 https://curecurrent.com/trials/a-study-evaluating-safety-and-efficacy-of-biod-123-compared-to-insulin-lispro-humalog-6656 https://curecurrent.com/trials/ffa-hypertension-and-inflammation-in-lean-and-obese-subjects-6657 https://curecurrent.com/trials/diabetic-kidney-disease-influence-of-exercise-therapy-on-physical-and-vascular-function-6658 https://curecurrent.com/trials/the-i-kan-study-internet-insulin-education-for-kansans-6659 https://curecurrent.com/trials/training-effects-on-skeletal-muscle-fatty-acid-metabolism-6660 https://curecurrent.com/trials/a-16-weeks-study-on-efficacy-and-safety-of-two-doses-of-empagliflozin-bi-10773-once-daily-versus-twice-daily-in-patients-6661 https://curecurrent.com/trials/mobile-motivation-for-health-promotion-among-adolescents-6662 https://curecurrent.com/trials/effect-of-raised-cbf-during-cea-on-cognition-in-dm-patients-6663 https://curecurrent.com/trials/recombinant-human-leptin-therapy-effects-on-insulin-action-6664 https://curecurrent.com/trials/accuracy-study-for-enhanced-meter-feature-6665 https://curecurrent.com/trials/a-phase-2-study-of-the-safety-and-efficacy-of-thymosin-beta-4-for-treating-corneal-wounds-6666 https://curecurrent.com/trials/effects-of-hyperglycemia-on-myocardial-perfusion-in-humans-with-and-without-type-2-diabetes-6667 https://curecurrent.com/trials/intervention-to-increase-screening-for-glucocorticoid-induced-diabetes-6668 https://curecurrent.com/trials/safety-effectiveness-on-vascular-structure-and-function-of-acz885-in-atherosclerosis-and-either-t2dm-or-igt-patients-6669 https://curecurrent.com/trials/effect-of-lycopene-and-isoflavones-on-glucose-metabolism-6670 https://curecurrent.com/trials/effects-of-treating-vitamin-d-deficiency-in-poorly-controlled-type-2-diabetes-6671 https://curecurrent.com/trials/nerve-decompression-for-ulcer-recurrence-avoidance-dura-6672 https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-in-patients-with-type-1-diabetes-mellitus-6673 https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-in-patients-with-type-2-diabetes-on-non-insulin-antidiab-6674 https://curecurrent.com/trials/pramlintide-in-adolescents-with-type-1-diabetes-6675 https://curecurrent.com/trials/improving-outcomes-in-diabetic-patients-during-cabg-surgery-by-optimizing-glycemic-control-6676 https://curecurrent.com/trials/study-of-saxagliptin-5-hydroxy-saxagliptin-and-metformin-concentrations-levels-in-pediatric-subjects-with-t2dm-6677 https://curecurrent.com/trials/ketosis-prone-diabetes-mellitus-kpdm-metformin-versus-sitagliptin-treatment-6678 https://curecurrent.com/trials/cognitive-behavioral-therapy-for-diabetic-neuropathic-pain-6679 https://curecurrent.com/trials/diabetes-telemedicine-consultation-a-systems-improvement-intervention-6680 https://curecurrent.com/trials/efficacy-of-exenatide-once-weekly-and-once-daily-insulin-glargine-in-patients-with-type-2-diabetes-treated-with-metformi-6681 https://curecurrent.com/trials/a-surgical-approach-to-the-management-of-type-ii-diabetes-mellitus-in-patients-with-a-bmi-between-25-35-kg-m2-6682 https://curecurrent.com/trials/a-phase-2-multicenter-randomized-double-blind-placebo-controlled-study-for-the-pain-of-diabetic-peripheral-neuropathy-6683 https://curecurrent.com/trials/safety-and-tolerability-study-of-oral-lgd-6972-for-type-2-diabetes-mellitus-6684 https://curecurrent.com/trials/sympathetic-nerve-activity-during-hypoglycemia-and-exercise-6685 https://curecurrent.com/trials/ezcast-dfu-study-with-portal-for-application-of-topical-medications-6686 https://curecurrent.com/trials/mechanisms-of-hypoglycemia-associated-autonomic-dysfunction-q-3-6687 https://curecurrent.com/trials/role-of-macronutrient-diet-composition-and-infant-metabolic-outcomes-in-gestational-diabetes-6688 https://curecurrent.com/trials/self-management-and-resourceful-transition-of-type-2-diabetes-with-stage-3-kidney-disease-6689 https://curecurrent.com/trials/managing-diabetes-in-pregnancy-using-cell-phone-internet-technology-6690 https://curecurrent.com/trials/intensive-case-diabetes-management-icdm-to-prevent-readmission-6691 https://curecurrent.com/trials/effects-of-dark-chocolate-on-exercise-capacity-and-mitochondrial-structure-and-function-6692 https://curecurrent.com/trials/partners-in-care-with-semi-structured-support-group-6693 https://curecurrent.com/trials/cardiometabolic-program-meets-ehealth-redesign-and-evaluation-for-optimal-reach-and-impact-6694 https://curecurrent.com/trials/effectiveness-of-v-go-for-patients-with-diabetes-in-a-real-world-setting-6695 https://curecurrent.com/trials/comparison-of-a-new-formulation-of-insulin-glargine-with-lantus-in-patients-with-type-1-diabetes-mellitus-on-basal-plus-6696 https://curecurrent.com/trials/mood-and-diabetes-empowerment-improvement-training-6697 https://curecurrent.com/trials/safety-and-efficacy-of-saxagliptin-plus-insulin-with-or-without-metformin-6698 https://curecurrent.com/trials/bioequivalence-study-of-saxagliptin-and-glucophage-combination-formulations-in-healthy-subjects-a-6699 https://curecurrent.com/trials/efficacy-and-safety-study-of-saxagliptin-metformin-immediate-release-ir-versus-metformin-ir-alone-in-type-2-diabetes-mel-6700 https://curecurrent.com/trials/safety-and-efficacy-study-of-subjects-that-are-taking-saxagliptin-added-onto-metformin-xr-compared-to-subjects-taking-me-6701 https://curecurrent.com/trials/mechanistic-assessment-of-the-properties-of-saxagliptin-in-subjects-undergoing-coronary-artery-bypass-graft-surgery-6702 https://curecurrent.com/trials/va-nephron-d-diabetes-in-nephropathy-study-6703 https://curecurrent.com/trials/treat-telemedicine-for-reach-education-access-and-treatment-6704 https://curecurrent.com/trials/pogo-automatic-blood-glucose-monitoring-system-clinical-study-6705 https://curecurrent.com/trials/neuropeptides-and-social-behavior-6706 https://curecurrent.com/trials/study-on-the-role-of-decompression-of-lower-extremity-nerves-for-the-treatment-of-patients-with-symptomatic-diabetic-neu-6707 https://curecurrent.com/trials/safety-and-tolerability-of-nova63035-corticosteroid-in-patients-with-diabetic-macular-edema-secondary-to-diabetic-retino-6708 https://curecurrent.com/trials/effective-treatment-of-sleep-apnea-in-prediabetes-to-reduce-cardiometabolic-risk-6709 https://curecurrent.com/trials/understanding-and-improving-diabetes-care-for-ethnic-minorities-6710 https://curecurrent.com/trials/local-modulation-of-immune-receptors-to-enhance-the-response-to-dendritic-cell-vaccination-in-metastatic-melanoma-6711 https://curecurrent.com/trials/project-diabetes-prescription-for-healthy-living-6712 https://curecurrent.com/trials/linking-self-management-and-primary-care-for-diabetes-2-6713 https://curecurrent.com/trials/diabetes-support-project-couples-intervention-6714 https://curecurrent.com/trials/bioequivalence-study-of-the-fixed-dose-combination-of-5-mg-saxagliptin-and-500-mg-metformin-xr-tablet-manufactured-in-mt-6715 https://curecurrent.com/trials/evaluation-of-an-orally-administered-medication-when-taken-in-conjunction-with-pramlintide-6716 https://curecurrent.com/trials/study-of-duodenal-jejunal-bypass-djb-as-a-potential-cure-for-type-2-diabetes-mellitus-6717 https://curecurrent.com/trials/clinical-utility-and-safety-of-pramlintide-in-subjects-with-type-1-and-type-2-diabetes-mellitus-6718 https://curecurrent.com/trials/bioequivalence-study-of-saxagliptin-and-glucophage-combination-formulations-in-healthy-subjects-b-6719 https://curecurrent.com/trials/study-of-impact-of-behavioral-intervention-exercise-nutrition-education-on-body-mass-index-bmi-6720 https://curecurrent.com/trials/study-to-evaluate-24-hour-blood-sugar-control-24-hour-mean-weighted-glucose-in-subjects-that-are-taking-saxagliptin-5-mg-6721 https://curecurrent.com/trials/minocycline-and-proteinuria-in-diabetic-nephropathy-6722 https://curecurrent.com/trials/a-phase-2b-study-of-gcs-100-in-patients-with-chronic-kidney-disease-caused-by-diabetes-6723 https://curecurrent.com/trials/impaired-family-dynamics-leads-to-non-compliance-in-type-i-diabetes-6724 https://curecurrent.com/trials/insulin-resistance-in-type-i-diabetes-in-pediatric-care-6725 https://curecurrent.com/trials/artificial-pancreas-control-system-in-an-outpatient-setting-6726 https://curecurrent.com/trials/safety-and-efficacy-of-gentamicin-topical-gel-appligel-g-for-treatment-of-mild-to-moderately-infected-diabetic-foot-ulce-6727 https://curecurrent.com/trials/oral-thiamine-for-the-treatment-of-painful-diabetic-peripheral-neuropathy-6728 https://curecurrent.com/trials/utility-of-crocsrx-clog-as-a-diabetic-house-shoe-a-pilot-study-6729 https://curecurrent.com/trials/cardiovascular-disease-education-and-problem-solving-training-in-people-with-type-2-diabetes-6730 https://curecurrent.com/trials/bioequivalence-study-of-2-5-mg-saxagliptin-and-500-mg-glucophage-in-tablets-and-a-fixed-dose-combination-tablet-in-healt-6731 https://curecurrent.com/trials/bioequivalence-study-of-the-fixed-dose-combination-of-5-mg-saxagliptin-1000-mg-metformin-xr-manufactured-in-mt-vernon-in-6732 https://curecurrent.com/trials/effect-of-a-low-advanced-glycation-end-products-age-diet-in-the-metabolic-syndrome-6733 https://curecurrent.com/trials/do-group-insulin-education-visits-reduce-barriers-to-insulin-initiation-6734 https://curecurrent.com/trials/drug-interaction-study-of-saxagliptin-in-combination-with-dapagliflozin-in-healthy-participants-6735 https://curecurrent.com/trials/bioequivalence-study-of-fixed-dose-combination-of-2-5-mg-saxagliptin-850-mg-metformin-tablet-relative-to-2-5-mg-onglyza-6736 https://curecurrent.com/trials/project-wellness-increasing-hiv-testing-among-west-african-immigrants-6737 https://curecurrent.com/trials/bioequivalence-study-of-500-mg-and-1000-mg-glucophage-metformin-tablets-in-healthy-subjects-6738 https://curecurrent.com/trials/multi-arm-intervention-diabetes-adherence-study-6739 https://curecurrent.com/trials/metformin-to-treat-obesity-in-children-with-insulin-resistance-6740 https://curecurrent.com/trials/feasibility-study-to-evaluate-safety-and-device-performance-of-the-hospital-glucose-management-system-hgms-6741 https://curecurrent.com/trials/a-study-assessing-saxagliptin-treatment-in-subjects-with-type-2-diabetes-who-are-not-controlled-with-diet-and-exercise-6742 https://curecurrent.com/trials/efficacy-and-safety-of-azilsartan-medoxomil-used-in-combination-with-metformin-in-participants-with-hypertension-and-dia-6743 https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-study-of-saxagliptin-in-healthy-subjects-6744 https://curecurrent.com/trials/lifestyle-modification-for-type-2-diabetes-involving-reduction-of-after-meal-blood-glucose-elevations-6745 https://curecurrent.com/trials/a-study-of-saxagliptin-in-subjects-with-type-2-diabetes-who-have-inadequate-blood-sugar-control-with-sulfonylureas-6746 https://curecurrent.com/trials/safety-study-of-repeated-doses-of-glucagon-on-animal-starch-in-the-liver-6747 https://curecurrent.com/trials/safety-and-efficacy-study-of-metaglidasen-in-type-2-diabetes-in-patients-suboptimally-controlled-on-insulin-6748 https://curecurrent.com/trials/safety-and-tolerability-study-of-mbx-2044-in-patients-with-type-2-diabetes-6749 https://curecurrent.com/trials/study-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-oral-doses-of-jtt-252-6750 https://curecurrent.com/trials/detection-of-human-beta-cell-death-in-type-1-diabetes-mellitus-t1dm-by-methylation-specific-polymerase-chain-reaction-pc-6751 https://curecurrent.com/trials/using-eeg-operant-conditioning-to-improve-trait-self-control-and-promote-healthy-behavior-6752 https://curecurrent.com/trials/regional-fatty-acid-metabolism-in-humans-6753 https://curecurrent.com/trials/study-assessing-saxagliptin-treatment-in-type-2-diabetic-subjects-who-are-not-controlled-with-metformin-alone-6754 https://curecurrent.com/trials/a-phase-3-study-of-bms-477118-in-combination-with-metformin-in-subjects-with-type-2-diabetes-who-are-not-controlled-with-6755 https://curecurrent.com/trials/study-of-bms-477118-as-monotherapy-with-titration-in-subjects-with-type-2-diabetes-who-are-not-controlled-with-diet-and-6756 https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-efficacy-of-three-dose-levels-of-mitoglitazone-in-type-2-diabetic-patients-6757 https://curecurrent.com/trials/veterans-service-organizations-and-my-healthevet-mhv-6758 https://curecurrent.com/trials/effective-care-management-of-depressed-diabetes-patients-the-positive-steps-study-6759 https://curecurrent.com/trials/use-of-online-personalized-health-record-system-to-promote-self-management-of-diabetes-6760 https://curecurrent.com/trials/adherence-and-intensification-of-medications-aim-implementation-study-6761 https://curecurrent.com/trials/racial-ethnic-differences-in-trust-mistrust-and-its-effect-on-diabetes-outcomes-6762 https://curecurrent.com/trials/nurse-telephone-management-of-cholesterol-in-diabetes-6763 https://curecurrent.com/trials/diabetes-medication-choice-6764 https://curecurrent.com/trials/opportunistic-screening-for-prediabetes-and-early-diabetes-in-primary-care-6765 https://curecurrent.com/trials/a-nutritional-intervention-for-diabetic-neuropathy-wccr-dn2-6766 https://curecurrent.com/trials/enhancing-fitness-in-older-pre-diabetic-veterans-6767 https://curecurrent.com/trials/diabetes-assistant-dias-control-to-range-ctr-nocturnal-closed-loop-camp-study-6768 https://curecurrent.com/trials/genetic-testing-for-type-2-diabetes-6769 https://curecurrent.com/trials/pilot-study-to-determine-effects-of-salsalate-in-type-1-diabetes-and-painful-peripheral-neuropathy-6770 https://curecurrent.com/trials/improving-insulin-therapy-with-enhanced-care-management-6771 https://curecurrent.com/trials/family-supported-smoking-cessation-for-chronically-ill-veterans-6772 https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-hemoglobin-a1c-6773 https://curecurrent.com/trials/bioequivalence-study-6774 https://curecurrent.com/trials/effect-of-physical-activity-on-metabolic-syndrome-in-pregnancy-fetal-outcome-6775 https://curecurrent.com/trials/a-placebo-controlled-randomized-safety-and-efficacy-study-to-evaluate-the-change-in-hemoglobin-a1c-levels-in-type-2-diab-6776 https://curecurrent.com/trials/metabolic-surgery-versus-medical-management-for-resolution-of-type-ii-diabetes-6777 https://curecurrent.com/trials/computed-tomography-and-biomarker-analysis-in-diagnosing-coronary-artery-disease-in-asymptomatic-patients-who-have-under-6778 https://curecurrent.com/trials/safety-of-exenatide-once-weekly-in-patients-with-type-2-diabetes-mellitus-treated-with-thiazolidinedione-alone-or-thiazo-6779 https://curecurrent.com/trials/a-study-of-ly2189265-compared-to-sitagliptin-in-participants-with-type-2-diabetes-mellitus-on-metformin-6780 https://curecurrent.com/trials/study-of-denagliptin-in-subjects-with-type-2-diabetes-mellitus-t2dm-6781 https://curecurrent.com/trials/safety-pharmacokinetics-pk-and-pharmacodynamics-pd-of-multiple-oral-bedtime-doses-of-ormd-0801-in-adult-patients-with-ty-6782 https://curecurrent.com/trials/pilot-study-of-vedic-medicine-for-type-2-diabetes-6783 https://curecurrent.com/trials/gsk189075-gw869682-or-placebo-in-type-2-diabetic-patients-6784 https://curecurrent.com/trials/a-retrospective-cohort-study-of-acute-pancreatitis-in-relation-to-use-of-exenatide-and-other-antidiabetic-agents-6785 https://curecurrent.com/trials/glycemic-control-of-carvedilol-versus-metoprolol-in-patients-with-type-ii-diabetes-mellitus-and-hypertension-6786 https://curecurrent.com/trials/effect-of-carvedilol-versus-metoprolol-on-glycemic-control-in-patients-with-type-ii-diabetes-and-hypertension-6787 https://curecurrent.com/trials/a-study-to-characterize-regimens-of-basal-insulin-intensified-with-either-symlin-or-rapid-acting-insulin-in-patients-wit-6788 https://curecurrent.com/trials/a-safety-study-to-assess-the-effects-of-therapeutic-and-supratherapeutic-exenatide-concentrations-on-qt-interval-in-heal-6789 https://curecurrent.com/trials/study-of-itca-650-exenatide-in-duros-in-subjects-with-type-2-diabetes-mellitus-6790 https://curecurrent.com/trials/effect-of-exenatide-on-abdominal-fat-distribution-in-patients-with-type-2-diabetes-pretreated-with-metformin-6791 https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-once-weekly-injection-versus-metformin-dipeptidyl-peptidase-4-inhibitor-or-thiazolidine-6792 https://curecurrent.com/trials/comparison-of-the-effect-of-exenatide-versus-sitagliptin-on-24-hour-average-glucose-in-patients-with-type-2-diabetes-on-6793 https://curecurrent.com/trials/neulasta-in-type-1-diabetes-6794 https://curecurrent.com/trials/effect-of-exercise-on-gait-and-balance-in-peripheral-neuropathy-6795 https://curecurrent.com/trials/a-study-assessing-saxagliptin-treatment-in-type-2-diabetic-subjects-who-are-not-controlled-with-tzd-therapy-alone-6796 https://curecurrent.com/trials/an-evaluation-of-exenatide-and-rosiglitazone-in-subjects-with-type-2-diabetes-mellitus-6797 https://curecurrent.com/trials/automated-calls-with-nurse-follow-up-to-improve-diabetes-ambulatory-care-6798 https://curecurrent.com/trials/study-to-evaluate-the-effectiveness-of-a-program-developed-to-improve-eye-care-for-veterans-with-diabetes-6799 https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-in-patients-with-type-2-diabetes-using-a-thiazolidinedione-or-a-thiazolidinedione-and-m-6800 https://curecurrent.com/trials/improving-diabetes-care-via-telephone-assessment-and-patient-education-6801 https://curecurrent.com/trials/improving-health-outcomes-of-diabetic-veterans-a-diabetic-self-management-program-6802 https://curecurrent.com/trials/proactive-diabetes-case-management-6803 https://curecurrent.com/trials/computer-assisted-access-to-specialist-expertise-6804 https://curecurrent.com/trials/effect-of-ac2993-compared-with-insulin-glargine-in-patients-with-type-2-diabetes-also-using-combination-therapy-with-sul-6805 https://curecurrent.com/trials/effectiveness-of-home-based-health-messaging-for-patients-with-hypertension-and-diabetes-6806 https://curecurrent.com/trials/an-evaluation-of-home-based-telemedicine-services-6807 https://curecurrent.com/trials/effect-on-weight-loss-of-exenatide-versus-placebo-6808 https://curecurrent.com/trials/type-2-diabetes-self-management-intervention-for-low-income-women-6809 https://curecurrent.com/trials/disease-management-and-educational-intervention-outcomes-in-high-risk-diabetics-6810 https://curecurrent.com/trials/a-pilot-study-of-effects-of-exenatide-on-body-weight-in-non-diabetic-obese-patients-6811 https://curecurrent.com/trials/improving-service-delivery-through-access-points-6812 https://curecurrent.com/trials/dermal-thermometry-and-self-care-of-high-risk-diabetic-patients-6813 https://curecurrent.com/trials/efficacy-and-safety-study-of-dermal-living-skin-replacement-to-treat-diabetic-foot-ulcers-6814 https://curecurrent.com/trials/a-study-to-evaluate-the-glycemic-effects-safety-and-tolerability-of-exenatide-once-weekly-in-subjects-with-type-2-diabet-6815 https://curecurrent.com/trials/a-study-to-compare-the-glycemic-effects-safety-and-tolerability-of-exenatide-once-weekly-to-those-of-sitagliptin-and-pio-6816 https://curecurrent.com/trials/periodontal-care-and-glycemic-control-in-diabetes-6817 https://curecurrent.com/trials/internet-based-diabetes-education-and-case-management-6818 https://curecurrent.com/trials/exercise-training-and-glucose-metabolism-in-aging-6819 https://curecurrent.com/trials/acute-cardiovascular-and-metabolic-effects-of-exercise-training-in-individuals-with-insulin-resistance-6820 https://curecurrent.com/trials/culturally-relevant-exercise-for-diabetes-cure-d-6821 https://curecurrent.com/trials/saxagliptin-treatment-in-subjects-with-type-2-diabetes-who-are-not-controlled-with-diet-and-exercise-6822 https://curecurrent.com/trials/a-study-to-evaluate-a-multiple-model-probabilistic-predictive-controller-mmppc-for-closed-loop-insulin-delivery-6823 https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-linagliptin-bi-1356-fixed-dose-combination-in-treatment-na-ve-and-metformi-6824 https://curecurrent.com/trials/a-mixed-methods-approach-to-the-development-and-testing-of-the-measure-of-drug-self-management-meds-6825 https://curecurrent.com/trials/effects-of-colesevelam-hcl-on-bile-acid-kinetics-6826 https://curecurrent.com/trials/cocoa-polyphenols-and-the-kidney-in-healthy-subjects-and-in-subjects-with-hypertension-and-diabetes-mellitus-6827 https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-adding-symlin-to-lantus-insulin-glargine-in-subjects-with-type-2-diabetes-6828 https://curecurrent.com/trials/milk-as-treatment-for-hypoglycemia-6829 https://curecurrent.com/trials/an-observational-study-evaluating-symlin-pramlintide-acetate-injection-use-in-insulin-using-patients-with-type-2-and-typ-6830 https://curecurrent.com/trials/a-pilot-open-label-clinical-trial-to-evaluate-the-combined-impact-of-two-mobile-health-products-on-health-outcomes-in-ov-6831 https://curecurrent.com/trials/gene-x-behavior-interaction-in-the-look-ahead-study-6832 https://curecurrent.com/trials/effects-of-quercetin-on-blood-sugar-and-blood-vessel-function-in-type-2-diabetes-6833 https://curecurrent.com/trials/single-site-single-subject-treatment-ind-with-mannkind-corporation-s-technosphere-inhalation-system-6834 https://curecurrent.com/trials/pilot-study-of-clinician-supported-patient-self-management-of-hospital-insulin-therapy-6835 https://curecurrent.com/trials/preventkd-prevent-risks-by-early-intervention-at-nighttime-in-type-1-diabetes-for-kidney-disease-6836 https://curecurrent.com/trials/repaglinide-for-adolescents-with-cystic-fibrosis-related-diabetes-6837 https://curecurrent.com/trials/effect-of-ac2993-with-or-without-immunosuppression-on-beta-cell-function-in-patients-with-type-i-diabetes-6838 https://curecurrent.com/trials/intensive-lifestyle-intervention-for-type-2-diabetics-the-kp-tlc-pilot-6839 https://curecurrent.com/trials/comparing-the-ultrasound-appearance-of-the-sciatic-nerve-with-its-appearance-under-a-microscope-6840 https://curecurrent.com/trials/pets-d-parent-education-thru-simulation-diabetes-6841 https://curecurrent.com/trials/promoting-physical-activity-among-patients-with-type-2-diabetes-6842 https://curecurrent.com/trials/ehealth-second-life-impacts-diabetes-education-self-management-6843 https://curecurrent.com/trials/d-vitamin-intervention-in-va-6844 https://curecurrent.com/trials/a-study-to-evaluate-symlin-in-adolescent-subjects-with-type-1-diabetes-mellitus-6845 https://curecurrent.com/trials/evaluation-of-a-nutritional-product-for-people-with-type-2-diabetes-6846 https://curecurrent.com/trials/mechanistic-study-of-the-systolic-blood-pressure-lowering-effect-of-dapagliflozin-in-type-2-diabetes-6847 https://curecurrent.com/trials/skin-blood-flow-in-patients-with-type-1-diabetes-mellitus-compared-to-normal-controls-6848 https://curecurrent.com/trials/an-open-label-study-examining-the-long-term-safety-of-exenatide-given-twice-daily-to-patients-with-type-2-diabetes-melli-6849 https://curecurrent.com/trials/evaluation-of-the-effect-on-glucose-control-of-ac2993-in-patients-with-type-2-diabetes-mellitus-treated-with-a-sulfonylu-6850 https://curecurrent.com/trials/extension-study-for-2993-112-6851 https://curecurrent.com/trials/evaluation-of-the-effect-on-glucose-control-of-ac2993-in-patients-with-type-2-diabetes-mellitus-treated-with-metformin-6852 https://curecurrent.com/trials/study-examining-exenatide-long-acting-release-in-subjects-with-type-2-diabetes-6853 https://curecurrent.com/trials/evaluation-of-the-effect-on-glucose-control-of-ac2993-in-patients-with-type-2-diabetes-mellitus-6854 https://curecurrent.com/trials/pf-04523655-dose-escalation-study-and-evaluation-of-pf-04523655-with-without-ranibizumab-in-diabetic-macular-edema-dme-6855 https://curecurrent.com/trials/study-of-the-safety-of-substituting-exenatide-for-insulin-in-patients-using-insulin-and-oral-antidiabetic-agents-6856 https://curecurrent.com/trials/effect-of-exenatide-on-24-hour-blood-glucose-profile-compared-with-placebo-in-patients-with-type-2-diabetes-6857 https://curecurrent.com/trials/effect-of-exenatide-monotherapy-on-glucose-control-in-subjects-with-type-2-diabetes-mellitus-6858 https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-and-tolerability-of-exenatide-in-adolescent-subjects-with-type-6859 https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-as-monotherapy-6860 https://curecurrent.com/trials/study-to-examine-the-effect-on-glucose-control-and-safety-tolerability-of-exenatide-given-two-times-a-day-to-subjects-wi-6861 https://curecurrent.com/trials/safety-and-efficacy-of-exenatide-in-patients-with-type-2-diabetes-using-thiazolidinediones-or-thiazolidinediones-and-met-6862 https://curecurrent.com/trials/sugar-text-a-randomized-controlled-trial-of-a-text-message-intervention-for-women-with-diabetes-in-pregnancy-6863 https://curecurrent.com/trials/evaluation-of-the-effect-on-glucose-control-and-the-safety-and-tolerability-of-ac2993-in-patients-with-type-2-diabetes-m-6864 https://curecurrent.com/trials/mechanisms-by-which-strength-training-ameliorates-the-metabolic-syndrome-6866 https://curecurrent.com/trials/fasting-predictors-of-ogtt-and-mmtt-response-6867 https://curecurrent.com/trials/long-term-use-cgm-system-assessment-in-adult-athletes-with-diabetes-mellitus-6868 https://curecurrent.com/trials/clinical-study-to-compare-various-dosing-and-titration-guidelines-of-insulin-delivered-via-v-go-in-patients-with-type-2-6869 https://curecurrent.com/trials/effect-of-lik066-on-glucose-absorption-in-patients-with-type-2-diabetes-mellitus-6870 https://curecurrent.com/trials/northern-manhattan-diabetes-community-outreach-project-6871 https://curecurrent.com/trials/effects-of-vitamin-c-and-e-on-endothelial-function-in-adolescent-diabetes-6872 https://curecurrent.com/trials/financial-incentives-for-medication-adherence-6873 https://curecurrent.com/trials/study-of-an-intervention-to-improve-problem-list-accuracy-and-use-6874 https://curecurrent.com/trials/a-study-of-the-effect-of-ly2189265-on-blood-pressure-and-heart-rate-in-type-2-diabetes-6875 https://curecurrent.com/trials/novel-type-2-diabetes-mellitus-preventive-therapies-6876 https://curecurrent.com/trials/safety-and-efficacy-of-cbx129801-in-patients-with-type-1-diabetes-6877 https://curecurrent.com/trials/metformin-and-transient-hyperglycemia-6878 https://curecurrent.com/trials/pharmacokinetics-pharmacodynamics-and-safety-of-alogliptin-in-children-adolescents-and-adults-with-type-2-diabetes-melli-6879 https://curecurrent.com/trials/outpatient-characterization-of-the-variability-of-insulin-secretory-parameters-in-the-meal-tolerance-and-the-maximal-sti-6880 https://curecurrent.com/trials/a-study-in-participants-with-type-2-diabetes-mellitus-6881 https://curecurrent.com/trials/study-of-oasis-ultra-in-diabetic-foot-ulcers-6882 https://curecurrent.com/trials/effect-of-medium-chain-fatty-acids-on-cognitive-function-during-acute-hypoglycemia-in-patients-with-type-1-diabetes-6883 https://curecurrent.com/trials/diabetes-visual-function-supplement-study-6884 https://curecurrent.com/trials/efficacy-and-safety-of-androgel-in-the-treatment-of-hypogonadal-and-low-testosterone-men-with-type-2-diabetes-6885 https://curecurrent.com/trials/a-study-in-participants-with-type-2-diabetes-mellitus-award-3-6886 https://curecurrent.com/trials/the-cantata-d2-trial-canagliflozin-treatment-and-trial-analysis-dpp-4-inhibitor-second-comparator-trial-6887 https://curecurrent.com/trials/insulin-secretion-in-diabetes-before-and-after-glycemic-control-6888 https://curecurrent.com/trials/safety-and-tolerability-of-ascending-intravenous-doses-of-pf-05231023-in-adult-subjects-with-type-2-diabetes-6889 https://curecurrent.com/trials/telerehabilitation-intervention-to-promote-exercise-for-diabetes-6890 https://curecurrent.com/trials/diabetes-in-the-elderly-prospective-study-6891 https://curecurrent.com/trials/a-research-trial-of-aralast-np-in-new-onset-diabetes-retain-part-ii-6892 https://curecurrent.com/trials/online-wound-electronic-medical-record-owemr-to-decrease-amputations-in-diabetics-6893 https://curecurrent.com/trials/intensive-insulin-therapy-in-patients-undergoing-coronary-artery-bypass-surgery-6894 https://curecurrent.com/trials/free-fatty-acid-induced-hypertension-in-obese-subjects-with-type-2-diabetes-6895 https://curecurrent.com/trials/the-medical-college-of-georgia-play-project-exercise-dose-and-insulin-sensitivity-in-obese-children-6896 https://curecurrent.com/trials/antioxidant-treatment-of-type-2-diabetes-6897 https://curecurrent.com/trials/sugar-replacement-sweeteners-and-blood-sugar-control-6898 https://curecurrent.com/trials/evaluation-of-the-yofimeter-glucometer-6899 https://curecurrent.com/trials/arthritis-foundation-exercise-program-10-keys-to-healthy-aging-prevention-research-center-6900 https://curecurrent.com/trials/a-study-in-adults-with-type-2-diabetes-6901 https://curecurrent.com/trials/comprehensive-postpartum-screening-strategies-for-women-with-gestational-diabetes-mellitus-gdm-6902 https://curecurrent.com/trials/insulin-action-during-pregnancy-in-woman-at-high-risk-for-gestational-diabetes-6903 https://curecurrent.com/trials/lobag30-diet-in-patients-on-metformin-6904 https://curecurrent.com/trials/hypoglycemia-associated-autonomic-failure-in-type-1-dm-q2-6905 https://curecurrent.com/trials/a-phase-1-open-label-safety-study-of-nka-in-patients-with-type-2-diabetes-6906 https://curecurrent.com/trials/metabolic-causes-of-thrombosis-in-type-2-diabetes-question-1-6907 https://curecurrent.com/trials/hypoglycemia-associated-autonomic-failure-in-type-1-dm-6908 https://curecurrent.com/trials/studies-of-organ-transplantation-in-animals-and-man-6909 https://curecurrent.com/trials/effects-of-ly2189265-on-glycemic-control-in-participants-with-type-2-diabetes-6910 https://curecurrent.com/trials/a-study-of-dose-titration-of-ly2189265-in-overweight-participants-with-type-2-diabetes-mellitus-6911 https://curecurrent.com/trials/individual-differences-in-diabetes-risk-role-of-sleep-disturbances-6912 https://curecurrent.com/trials/diabetes-depression-care-management-adoption-trial-6913 https://curecurrent.com/trials/effects-of-uri-on-diabetic-subjects-utilizing-technosphere-insulin-after-a-meal-challenge-6914 https://curecurrent.com/trials/a-2-month-safety-follow-up-trial-6915 https://curecurrent.com/trials/simulated-diabetes-training-for-resident-physicians-6916 https://curecurrent.com/trials/sitagliptin-in-combination-with-metformin-and-sulfonylurea-6917 https://curecurrent.com/trials/a-study-to-compare-analytes-in-blood-collected-using-an-investigational-collection-device-with-a-commercial-predicate-6918 https://curecurrent.com/trials/a-study-to-compare-analyte-levels-in-blood-collected-using-an-investigational-collection-device-with-a-commercial-predic-6919 https://curecurrent.com/trials/randomized-placebo-controlled-2-period-single-blind-sequential-multiple-ascending-dose-study-6920 https://curecurrent.com/trials/effects-of-pioglitazone-on-high-density-lipoprotein-hdl-function-in-persons-with-diabetes-6921 https://curecurrent.com/trials/a-safety-and-efficacy-study-comparing-naltrexone-sr-bupropion-sr-and-placebo-in-obese-subjects-with-type-2-diabetes-6922 https://curecurrent.com/trials/a-pilot-intervention-study-of-health-coaching-to-promote-diabetes-self-care-in-the-community-6923 https://curecurrent.com/trials/postpartum-glucose-tolerance-with-levonorgesterel-iud-use-in-women-with-recent-gestational-diabetes-6924 https://curecurrent.com/trials/dulce-digital-project-dulce-2-0-texting-study-6925 https://curecurrent.com/trials/naturlose-d-tagatose-efficacy-evaluation-trial-6926 https://curecurrent.com/trials/microbes-and-bariatric-surgery-6927 https://curecurrent.com/trials/vascular-effects-of-carvedilol-versus-metoprolol-in-hypertensive-patients-with-type-2-diabetes-6928 https://curecurrent.com/trials/telehealth-remote-patient-monitoring-study-in-people-with-type-2-diabetes-6929 https://curecurrent.com/trials/enhanced-spanish-drug-label-study-to-promote-patient-understanding-and-use-6930 https://curecurrent.com/trials/performance-evaluation-of-a-non-invasive-glucose-monitor-as-compared-to-cgm-data-acquired-by-the-ipro2-6931 https://curecurrent.com/trials/ranolazine-when-added-to-glimepiride-in-subjects-with-type-2-diabetes-mellitus-6932 https://curecurrent.com/trials/molecular-and-clinical-effects-of-green-tea-and-fermented-papaya-preparation-on-diabetes-and-cardiovascular-diseases-6933 https://curecurrent.com/trials/surgical-treatment-of-type-2-diabetes-in-non-morbidly-obese-patients-6934 https://curecurrent.com/trials/vitamin-d-glucose-control-and-insulin-sensitivity-in-african-americans-6935 https://curecurrent.com/trials/feasibility-study-of-a-modular-control-to-range-system-in-type-1-diabetes-mellitus-6936 https://curecurrent.com/trials/exercise-and-diabetes-an-observational-study-of-exercise-and-blood-glucose-control-6937 https://curecurrent.com/trials/clinical-utility-of-sudoscan-in-the-pediatric-population-6938 https://curecurrent.com/trials/a-pilot-study-examining-a-reinforcement-approach-to-improve-diabetes-management-6939 https://curecurrent.com/trials/diabetes-virtual-trek-obesity-and-diabetes-prevention-through-science-enrichment-6940 https://curecurrent.com/trials/obesity-and-diabetes-prevention-through-science-enrichment-6941 https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-effect-of-naturlose-tagatose-6942 https://curecurrent.com/trials/chronic-care-management-patient-relationship-management-proof-of-concept-6943 https://curecurrent.com/trials/effect-of-inpatient-diabetes-management-on-outpatient-glycemic-control-6944 https://curecurrent.com/trials/type-2-diabetes-evaluation-of-ranolazine-in-subjects-with-chronic-stable-angina-6945 https://curecurrent.com/trials/a-safety-and-efficacy-study-of-canagliflozin-in-older-patients-55-to-80-years-of-age-with-type-2-diabetes-mellitus-6946 https://curecurrent.com/trials/safety-and-efficacy-of-lx4211-with-metformin-in-type-2-diabetes-patients-with-inadequate-glycemic-control-on-metformin-6947 https://curecurrent.com/trials/study-of-a-cell-phone-system-to-improve-health-of-youth-with-diabetes-6948 https://curecurrent.com/trials/type-1-diabetes-mellitus-effect-on-bone-mineral-density-6949 https://curecurrent.com/trials/clinical-trial-evaluating-the-efficacy-and-safety-of-technosphere-inhalation-insulin-ti-inhalation-powder-using-the-gen2-6950 https://curecurrent.com/trials/evaluation-of-a-lifestyle-intervention-for-employees-with-prediabetes-6951 https://curecurrent.com/trials/safety-and-efficacy-of-technosphere-insulin-inhalation-powder-ti-inhalation-powder-when-an-optimal-dose-is-taken-with-va-6952 https://curecurrent.com/trials/education-counseling-and-drug-therapy-to-reduce-symptoms-of-metabolic-syndrome-6953 https://curecurrent.com/trials/comparison-of-psyllium-and-microcrystalline-cellulose-on-glycemic-measures-in-subjects-with-impaired-fasting-glucose-6954 https://curecurrent.com/trials/ranolazine-monotherapy-in-subjects-with-type-2-diabetes-mellitus-6955 https://curecurrent.com/trials/effectiveness-study-of-community-based-peer-led-education-on-weight-loss-and-diabetes-6956 https://curecurrent.com/trials/effect-of-genetic-variants-in-mate1-and-oct3-on-the-pharmacodynamics-of-metformin-in-african-americans-6957 https://curecurrent.com/trials/clinical-trial-evaluating-technosphere-insulin-versus-insulin-aspart-in-subjects-with-type-1-diabetes-mellitus-over-a-24-6958 https://curecurrent.com/trials/a-study-to-compare-the-effect-of-giving-dulaglutide-using-an-auto-injector-versus-a-manual-syringe-6959 https://curecurrent.com/trials/study-of-medical-assistant-health-coaching-in-primary-care-for-patients-with-chronic-conditions-6960 https://curecurrent.com/trials/comparison-of-lantus-and-neutral-protamine-hagedorn-nph-insulin-in-the-dawn-phenomenon-6961 https://curecurrent.com/trials/30-week-parallel-group-comparison-study-of-linagliptin-pioglitazone-5-15-5-30-and-5-45-mg-qd-versus-respective-monothera-6962 https://curecurrent.com/trials/effect-of-different-fixed-pramlintide-insulin-dose-ratios-on-postprandial-glucose-in-t1dm-6963 https://curecurrent.com/trials/efficacy-of-lubiprostone-in-combination-with-standard-peg-preparation-6964 https://curecurrent.com/trials/comparison-of-technosphere-insulin-versus-technosphere-powder-placebo-in-insulin-naive-subjects-with-type-2-diabetes-mel-6965 https://curecurrent.com/trials/renal-effects-of-two-iodinated-contrast-media-in-patients-at-risk-undergoing-computed-tomography-6966 https://curecurrent.com/trials/a-pilot-study-for-the-evaluation-of-minocycline-as-a-microglia-inhibitor-in-the-treatment-of-diabetic-macular-edema-6967 https://curecurrent.com/trials/safety-of-inhaled-insulin-with-type-1-and-type-2-diabetes-6968 https://curecurrent.com/trials/efficacy-and-safety-in-subjects-with-type-2-diabetes-receiving-subcutaneous-basal-insulin-and-prandial-inhalation-of-tec-6969 https://curecurrent.com/trials/safety-and-efficacy-of-technosphere-insulin-inhalation-powder-and-lantus-compared-to-humalog-and-lantus-over-16-weeks-6970 https://curecurrent.com/trials/efficacy-and-safety-of-prandial-inhalation-of-technosphere-insulin-in-combination-with-metformin-or-technosphere-insulin-6971 https://curecurrent.com/trials/efficacy-safety-of-inhaled-insulin-in-type-1-diabetes-6972 https://curecurrent.com/trials/an-open-label-multi-center-international-three-year-safety-and-tolerability-follow-on-trial-6973 https://curecurrent.com/trials/a-study-designed-to-compare-2-dose-strengths-of-ti-inhalation-powder-in-adults-with-type-1-diabetes-mellitus-and-to-comp-6974 https://curecurrent.com/trials/assess-measurements-of-wireless-cardiac-output-device-6975 https://curecurrent.com/trials/weight-loss-study-for-people-with-type-2-diabetes-6976 https://curecurrent.com/trials/the-ohsu-pregnancy-exercise-nutrition-pen-program-6977 https://curecurrent.com/trials/phase-1-multicenter-single-ascending-dose-study-to-assess-the-safety-tolerability-pharmacokinetic-and-pharmacodynamic-re-6978 https://curecurrent.com/trials/assessing-the-risk-of-developing-type-ii-diabetes-using-serum-biomarkers-in-patients-diagnosed-with-obstructive-sleep-ap-6979 https://curecurrent.com/trials/a-study-in-adults-with-type-1-diabetes-6980 https://curecurrent.com/trials/a-study-comparing-the-effect-of-dulaglutide-with-liraglutide-in-type-2-diabetes-6981 https://curecurrent.com/trials/a-study-in-participants-with-type-2-diabetes-mellitus-award-4-6982 https://curecurrent.com/trials/a-study-of-the-effect-of-ly2189265-on-two-blood-pressure-drugs-6983 https://curecurrent.com/trials/respond-restoring-equilibrium-and-wound-stimulation-to-promote-healing-of-non-healing-dfus-6984 https://curecurrent.com/trials/a-study-of-the-effect-of-dulaglutide-on-how-the-body-handles-oral-contraceptive-in-healthy-female-participants-6985 https://curecurrent.com/trials/a-study-to-compare-the-concentrations-of-ly2189265-after-different-methods-of-administration-to-healthy-volunteers-6986 https://curecurrent.com/trials/a-study-of-ly2189265-and-sitagliptin-in-participants-with-type-2-diabetes-6987 https://curecurrent.com/trials/a-study-of-the-effect-of-dulaglutide-on-the-action-of-warfarin-in-healthy-participants-6988 https://curecurrent.com/trials/study-of-safety-tolerability-and-pharmacokinetics-of-single-oral-jtt-251-doses-in-healthy-and-type-2-diabetic-subjects-6989 https://curecurrent.com/trials/a-study-of-the-effect-of-dulaglutide-on-how-body-handles-digoxin-in-healthy-participants-6990 https://curecurrent.com/trials/efficacy-and-safety-of-bi-10773-in-combination-with-insulin-in-patients-with-type-2-diabetes-6991 https://curecurrent.com/trials/effect-of-fish-oil-omega-3-fatty-acids-on-arteries-6992 https://curecurrent.com/trials/the-impact-of-fitness-on-vascular-dysfunction-in-adolescents-with-type-1-diabetes-6993 https://curecurrent.com/trials/safety-and-efficacy-of-bgp-15-in-patients-with-type-2-diabetes-mellitus-6994 https://curecurrent.com/trials/topical-plurogel-pn-for-the-treatment-of-mildly-infected-diabetic-foot-ulcers-6995 https://curecurrent.com/trials/the-effect-of-ethanol-on-overnight-glucose-regulation-in-type-2-6996 https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-lgd-6972-in-healthy-subjects-and-subjects-6997 https://curecurrent.com/trials/topical-plurogel-n-for-the-treatment-of-mildly-infected-diabetic-foot-ulcers-6998 https://curecurrent.com/trials/a-phase-3-study-of-ranolazine-in-subjects-with-type-2-diabetes-who-are-inadequately-controlled-on-metformin-alone-6999 https://curecurrent.com/trials/a-trial-to-assess-the-efficacy-and-safety-of-spm-927-in-subjects-with-painful-distal-diabetic-neuropathy-7000 https://curecurrent.com/trials/trial-to-assess-the-efficacy-and-safety-of-spm-927-200-400-and-600mg-day-in-subjects-with-painful-distal-diabetic-neurop-7001 https://curecurrent.com/trials/the-effects-of-the-food-preservative-propionic-acid-in-post-prandial-metabolism-7002 https://curecurrent.com/trials/improving-control-and-reducing-the-risk-of-hypoglycemic-episodes-in-type-1-diabetes-7003 https://curecurrent.com/trials/multiple-dose-study-of-pf-05231023-in-obese-adult-subjects-7004 https://curecurrent.com/trials/an-efficacy-safety-and-tolerability-study-of-canagliflozin-in-the-treatment-of-patients-with-type-2-diabetes-mellitus-wi-7005 https://curecurrent.com/trials/islet-after-kidney-transplant-for-type-1-diabetes-7006 https://curecurrent.com/trials/the-multi-sensor-distance-accuracy-study-7007 https://curecurrent.com/trials/outpatient-control-to-range-system-and-monitoring-testing-7008 https://curecurrent.com/trials/effects-of-standing-on-glycemia-in-prediabetic-adults-7009 https://curecurrent.com/trials/goodmoms-a-multimodel-pregnancy-and-postpartum-intervention-for-gestational-diabetics-7010 https://curecurrent.com/trials/early-feasibility-study-2-of-outpatient-control-to-range-testing-system-efficacy-7011 https://curecurrent.com/trials/safety-and-efficacy-of-peg-encapsulated-islet-allografts-implanted-in-type-i-diabetic-recipients-7012 https://curecurrent.com/trials/idecide-decido-diabetes-medication-decision-support-study-7013 https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combination-tablets-of-canagliflozin-and-metformin-extended-release-xr-with-res-7014 https://curecurrent.com/trials/low-glycemic-load-diets-in-latino-children-at-risk-for-type-2-diabetes-7015 https://curecurrent.com/trials/peer-led-self-management-support-in-real-world-clinical-and-community-settings-7016 https://curecurrent.com/trials/safety-study-of-subcutaneously-injected-prandial-insulin-ph20-np-compared-to-insulin-lispro-injection-in-participants-wi-7017 https://curecurrent.com/trials/effect-of-statins-on-oxidative-stress-and-endothelial-progenitor-cells-7018 https://curecurrent.com/trials/the-association-between-unprotected-standing-walking-and-wound-healing-in-diabetes-7019 https://curecurrent.com/trials/counter-regulatory-impairment-and-the-effect-of-microvascular-insulin-transfer-in-type-1-diabetes-mellitus-7020 https://curecurrent.com/trials/pediatric-diabetics-type-1-using-insupatch-7021 https://curecurrent.com/trials/development-of-a-behavioral-observer-for-type-1-diabetes-mellitus-7022 https://curecurrent.com/trials/comparison-of-phase-variance-optical-coherence-tomography-and-fluorescein-angiography-in-retinovascular-imaging-7023 https://curecurrent.com/trials/pilot-study-of-closed-loop-glucose-control-in-people-with-type-1-diabetes-bpk004-7024 https://curecurrent.com/trials/a-nutritional-intervention-for-diabetic-neuropathy-7025 https://curecurrent.com/trials/evaluation-of-the-effect-of-the-insupatch-device-on-insulin-pharmacokinetics-in-clamp-studies-7026 https://curecurrent.com/trials/evaluation-of-the-safety-use-of-the-insupatch-device-in-daily-life-conditions-7027 https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combination-tablets-of-canagliflozin-and-metformin-extended-release-xr-with-res-7028 https://curecurrent.com/trials/a-study-to-compare-analyte-levels-in-blood-samples-collected-using-the-tap20-c-device-with-results-obtained-by-fingersti-7029 https://curecurrent.com/trials/glycemic-response-to-high-amylose-rice-7030 https://curecurrent.com/trials/diet-and-activity-promotion-among-older-working-adults-7031 https://curecurrent.com/trials/determination-of-safety-tolerability-pharmacokinetics-food-effect-pharmacodynamics-of-single-multiple-doses-of-p11187-7032 https://curecurrent.com/trials/eating-disorders-in-type-1-diabetes-mechanisms-of-comorbidity-7033 https://curecurrent.com/trials/simcare-physician-intervention-to-improve-diabetes-care-7034 https://curecurrent.com/trials/safety-efficacy-study-of-subcutaneously-injected-prandial-insulins-compared-to-insulin-lispro-alone-in-patients-with-typ-7035 https://curecurrent.com/trials/liquid-meal-study-with-insulin-lispro-with-without-recombinant-human-hyaluronidase-ph20-rhuph20-and-regular-human-insuli-7036 https://curecurrent.com/trials/hypoglycemia-prevention-after-exercise-in-adolescent-t1dm-patients-using-a-control-to-range-system-7037 https://curecurrent.com/trials/prosthetic-components-and-stability-in-amputee-gait-7038 https://curecurrent.com/trials/feasibility-study-of-closed-loop-control-in-type-1-diabetes-using-heart-rate-monitoring-as-an-exercise-marker-7039 https://curecurrent.com/trials/vacuum-suspension-effects-on-tissue-oxygenation-activity-and-fit-7040 https://curecurrent.com/trials/the-careful-prevention-trial-7041 https://curecurrent.com/trials/the-avoiding-diabetes-thru-action-plan-targeting-pilot-randomized-control-trial-7042 https://curecurrent.com/trials/sensor-based-balance-training-in-diabetes-a-virtual-reality-paradigm-7043 https://curecurrent.com/trials/daily-tadalafil-and-gastric-emptying-time-in-diabetic-gastroparesis-7044 https://curecurrent.com/trials/subcutaneous-administration-of-lisofylline-to-healthy-normal-subjects-and-subjects-with-type-1-diabetes-7045 https://curecurrent.com/trials/randomized-double-blind-crossover-pharmacokinetic-pk-and-glucodynamic-gd-study-of-continuous-subcutaneous-insulin-infusi-7046 https://curecurrent.com/trials/effect-of-maraviroc-on-endothelial-function-in-hiv-infected-patients-7047 https://curecurrent.com/trials/using-santyl-on-diabetic-foot-ulcers-7048 https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-androxal-in-controlling-blood-glucose-in-men-with-type-2-diabetes-mellitus-7049 https://curecurrent.com/trials/comparison-of-apidra-to-regular-insulin-in-hospitalized-patients-7050 https://curecurrent.com/trials/pilot-study-of-the-effect-of-mn-504-cobiotic-formulation-on-the-efficacy-and-tolerability-of-metformin-7051 https://curecurrent.com/trials/effects-of-a-homeopathic-anti-inflammatory-topical-cream-on-ulcers-and-neuropathy-in-the-diabetic-foot-7052 https://curecurrent.com/trials/xenin-25-novel-regulator-of-insulin-secretion-and-beta-cell-function-7053 https://curecurrent.com/trials/pharmacokinetic-and-glucodynamic-crossover-study-of-subcutaneously-sc-administered-insulin-lispro-recombinant-human-hyal-7054 https://curecurrent.com/trials/personalized-cardiovascular-risk-information-to-initiate-and-maintain-health-behavior-changes-7055 https://curecurrent.com/trials/a-randomized-double-blind-study-testing-the-effects-of-pregabalin-on-diabetic-neuropathy-7056 https://curecurrent.com/trials/a-pilot-study-of-moderate-hyperbilirubinemia-in-type-1-diabetes-mellitus-7057 https://curecurrent.com/trials/a-mobile-based-diabetes-prevention-program-7058 https://curecurrent.com/trials/effects-of-aerobic-exercise-in-patients-with-pre-diabetes-7059 https://curecurrent.com/trials/does-saxagliptin-reduce-the-risk-of-cardiovascular-events-when-used-alone-or-added-to-other-diabetes-medications-7060 https://curecurrent.com/trials/characterization-of-the-variability-of-insulin-secretory-parameters-in-the-meal-tolerance-and-the-maximal-stimulation-te-7061 https://curecurrent.com/trials/supreme-dm-diabetes-mellitis-treatment-study-7062 https://curecurrent.com/trials/tailored-case-management-for-diabetes-and-hypertension-7063 https://curecurrent.com/trials/exercise-dose-response-effects-in-prediabetes-7064 https://curecurrent.com/trials/safety-and-efficacy-of-empagliflozin-bi-10773-and-sitagliptin-versus-placebo-over-76-weeks-in-patients-with-type-2-diabe-7065 https://curecurrent.com/trials/a-crossover-study-of-the-acute-effects-of-olanzapine-in-healthy-volunteers-7066 https://curecurrent.com/trials/pharmacokinetics-of-a-fixed-dose-combination-of-canagliflozin-metformin-coadministered-with-food-7067 https://curecurrent.com/trials/safety-and-efficacy-of-ingap-peptide-in-patients-with-type-1-diabetes-7068 https://curecurrent.com/trials/an-evaluation-of-the-efficacy-and-safety-of-e2007-in-patients-with-painful-diabetic-neuropathy-7069 https://curecurrent.com/trials/effects-of-resistant-starch-in-a-baked-snack-bar-on-a-post-prandial-glycemic-and-insulinemic-response-7070 https://curecurrent.com/trials/safety-and-efficacy-of-ingap-peptide-in-patients-with-type-2-diabetes-7071 https://curecurrent.com/trials/diabetes-group-visits-7072 https://curecurrent.com/trials/veteran-health-study-7073 https://curecurrent.com/trials/effect-of-a-high-protein-diet-on-the-24-hour-profile-of-ghrelin-gh-growth-hormone-and-igf-1-insulin-like-growth-factor-1-7074 https://curecurrent.com/trials/a-very-high-fiber-diet-versus-a-low-carbohydrate-diet-for-weight-loss-7075 https://curecurrent.com/trials/efficacy-and-safety-of-metoclopramide-nasal-spray-solution-in-diabetic-patients-with-gastroparesis-7076 https://curecurrent.com/trials/correlation-of-plasma-endothelial-cell-activity-with-cardiovascular-events-in-patients-with-diabetes-mellitus-type-2-7077 https://curecurrent.com/trials/safety-and-efficacy-of-linagliptin-bi-1356-as-monotherapy-or-in-combination-in-type-2-dm-7078 https://curecurrent.com/trials/safety-and-efficacy-of-linagliptin-in-type-2-diabetes-mellitus-patients-with-moderate-to-severe-renal-impairment-7079 https://curecurrent.com/trials/non-traditional-cardiovascular-risk-factors-and-atherosclerosis-in-type-2-diabetes-7080 https://curecurrent.com/trials/randomized-double-blind-db-placebo-controlled-18-week-study-of-linagliptin-bi-1356-in-type-2-diabetic-patients-with-insu-7081 https://curecurrent.com/trials/a-randomised-db-placebo-controlled-study-of-bi-1356-for-18-weeks-followed-by-a-34-week-double-blind-extension-period-pla-7082 https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-trial-with-linagliptin-bi-1356-5mg-in-african-american-type-2-diabetic-patients-7083 https://curecurrent.com/trials/safety-and-efficacy-of-once-daily-krp-104-in-type-2-diabetics-with-inadequate-glycemic-control-on-metformin-alone-7084 https://curecurrent.com/trials/efficacy-and-safety-study-with-empagliflozin-bi-10773-vs-placebo-as-add-on-to-metformin-or-metformin-plus-sulfonylurea-o-7085 https://curecurrent.com/trials/safety-and-efficacy-of-bi-10773-as-add-on-to-insulin-regimen-in-patients-with-type-2-diabetes-mellitus-7086 https://curecurrent.com/trials/prevention-of-type-2-diabetes-in-children-with-a-family-based-healthy-lifestyle-program-7087 https://curecurrent.com/trials/a-bioequivalence-study-of-the-fixed-dose-combination-tablets-of-canagliflozin-and-metformin-extended-release-xr-with-res-7088 https://curecurrent.com/trials/strategies-for-inflammation-and-cardiovascular-disease-cvd-prevention-7089 https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-in-type-2-diabetes-patients-on-a-background-of-pioglitazone-alone-or-with-7090 https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-versus-placebo-and-sitagliptin-over-24-weeks-in-patients-with-type-2-diabe-7091 https://curecurrent.com/trials/empagliflozin-bi-10773-in-type-two-diabetes-t2d-patients-open-label-extension-7092 https://curecurrent.com/trials/efficacy-and-safety-of-empagliflozin-bi-10773-in-patients-with-type-2-diabetes-and-renal-impairment-7093 https://curecurrent.com/trials/dapagliflozin-dppiv-inhibitor-add-on-study-7094 https://curecurrent.com/trials/bi-10773-add-on-to-metformin-in-patients-with-type-2-diabetes-7095 https://curecurrent.com/trials/effects-of-resistant-starch-in-a-beverage-on-post-prandial-glycemic-and-insulinemic-responses-7096 https://curecurrent.com/trials/insulin-detemir-versus-nph-insulin-in-hospitalized-patients-with-diabetes-7097 https://curecurrent.com/trials/b-lymphocyte-immunotherapy-in-islet-transplantation-for-initial-islet-graft-failure-7098 https://curecurrent.com/trials/study-of-a-home-delivered-meal-program-on-obese-elderly-african-american-subjects-with-type-2-diabetes-mellitus-dm-7099 https://curecurrent.com/trials/effects-of-a-spiced-meat-patty-on-inflammation-in-men-with-type-2-diabetes-7100 https://curecurrent.com/trials/an-rct-evaluation-of-a-diabetes-dashboard-team-model-in-primary-care-7101 https://curecurrent.com/trials/evaluating-a-web-based-cardiovascular-disease-risk-factor-reduction-program-among-american-indians-7102 https://curecurrent.com/trials/haptoglobin-phenotype-vitamin-e-and-high-density-lipoprotein-hdl-function-in-type-1-diabetes-7103 https://curecurrent.com/trials/personalized-diabetic-kidney-disease-risk-info-to-initiate-and-maintain-health-behavior-changes-7104 https://curecurrent.com/trials/transition-of-adolescents-and-young-adults-with-diabetes-from-pediatric-to-adult-care-7105 https://curecurrent.com/trials/evaluation-of-the-accuracy-of-the-abbott-sensor-based-interstitial-glucose-monitoring-system-7106 https://curecurrent.com/trials/taste-perception-and-chronic-disease-risk-7107 https://curecurrent.com/trials/fatty-acid-binding-protein-2-fabp2-ancillary-proposal-7108 https://curecurrent.com/trials/markers-and-mechanisms-of-vascular-disease-in-type-ii-diabetes-7109 https://curecurrent.com/trials/evaluation-of-the-blood-levels-of-the-drug-lixisenatide-the-plasma-glucose-levels-and-safety-in-paediatric-and-adult-pat-7110 https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-explores-what-the-body-does-to-the-drug-and-pharmacodynamic-7111 https://curecurrent.com/trials/novel-adjuvants-for-peptide-based-melanoma-vaccines-7112 https://curecurrent.com/trials/role-of-mobile-technology-to-improve-diabetes-care-in-adults-with-type-1-diabetes-the-remote-t1d-study-a-pilot-study-7113 https://curecurrent.com/trials/study-of-insulin-resistance-and-endometrial-cancer-in-harris-county-texas-7114 https://curecurrent.com/trials/personalized-exercise-for-adolescents-with-diabetes-7115 https://curecurrent.com/trials/the-study-of-exenatide-action-on-vessel-function-in-type-2-diabetes-and-prediabetes-7116 https://curecurrent.com/trials/linagliptin-and-metformin-versus-linagliptin-in-newly-diagnosed-untreated-type-2-diabetes-7117 https://curecurrent.com/trials/efficacy-of-colesevelam-in-subjects-with-type-1-diabetes-mellitus-7118 https://curecurrent.com/trials/safety-and-efficacy-in-type-2-diabetic-patients-with-severe-chronic-renal-impairment-5-mg-bi-1356-linagliptin-vs-placebo-7119 https://curecurrent.com/trials/care-transitions-for-complex-patient-cycle-1-and-cycle-2-7120 https://curecurrent.com/trials/aldosterone-breakthrough-during-diovan-tekturna-and-combination-therapy-in-patients-with-proteinuric-kidney-disease-7121 https://curecurrent.com/trials/cardiovascular-risk-clinic-7122 https://curecurrent.com/trials/amg-151-amgen-protocol-number-20100761-7123 https://curecurrent.com/trials/transdermal-continuous-oxygen-therapy-for-diabetic-foot-ulcers-7124 https://curecurrent.com/trials/mitochondrial-dysfunction-in-diabetes-7125 https://curecurrent.com/trials/pgc-1-and-mitochondrial-dysfunction-in-diabetes-7126 https://curecurrent.com/trials/evaluating-the-safety-and-tolerability-of-oravescent-fentanyl-for-opioid-tolerant-patients-with-noncancer-related-breakt-7127 https://curecurrent.com/trials/hope-pilot-for-veterans-with-complex-diabetes-7128 https://curecurrent.com/trials/efficacy-study-of-lucentis-in-the-treatment-of-diabetic-macular-edema-7129 https://curecurrent.com/trials/detection-of-c-peptide-in-youth-with-longstanding-type-1-diabetes-mellitus-7130 https://curecurrent.com/trials/using-salsalate-to-target-adipocyte-macrophage-infiltration-7131 https://curecurrent.com/trials/nurse-led-case-management-for-diabetes-and-cardiovascular-disease-patients-with-depression-7132 https://curecurrent.com/trials/cardiovascular-outcomes-study-of-alogliptin-in-patients-with-type-2-diabetes-and-acute-coronary-syndrome-7133 https://curecurrent.com/trials/continuous-glucose-monitoring-cgm-in-subjects-with-type-2-diabetes-7134 https://curecurrent.com/trials/study-of-iv-ym087-to-assess-efficacy-and-safety-in-patients-with-euvolemic-or-hypervolemic-hyponatremia-7135 https://curecurrent.com/trials/pramlintide-combined-with-model-predictive-control-algorithm-7136 https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-clinical-effect-of-nexagon-as-a-topical-treatment-for-subjects-with-a-diabetic-foo-7137 https://curecurrent.com/trials/flavanol-rich-cocoa-and-cerebral-blood-flow-7138 https://curecurrent.com/trials/accuracy-of-blood-glucose-detection-by-diabetes-alert-dogs-7139 https://curecurrent.com/trials/evaluation-of-a-simulation-based-educational-tool-for-personalized-feedback-in-insulin-therapy-management-7140 https://curecurrent.com/trials/randomized-controlled-trial-of-vitamin-d3-in-diabetic-kidney-disease-7141 https://curecurrent.com/trials/intensive-discharge-intervention-in-diabetes-7142 https://curecurrent.com/trials/coronary-artery-revascularization-in-diabetes-7143 https://curecurrent.com/trials/mitochondrial-dysfunction-in-type-2-diabetes-mellitus-and-capacity-for-fat-oxidation-during-exercise-7144 https://curecurrent.com/trials/cost-effectiveness-and-quality-of-life-in-heart-failure-patients-with-diabetes-7145 https://curecurrent.com/trials/blood-pressure-telemonitoring-and-goal-blood-pressure-in-diabetes-7146 https://curecurrent.com/trials/study-of-insulin-lispro-in-participants-with-inadequately-controlled-type-2-diabetes-7147 https://curecurrent.com/trials/study-of-raisins-versus-alternative-snacks-in-patients-with-type-2-diabetes-mellitus-7148 https://curecurrent.com/trials/a-safety-tolerability-pharmacokinetics-and-pharmacodynamics-study-of-jnj-28431754-in-patients-with-type-2-diabetes-melli-7149 https://curecurrent.com/trials/computer-detection-of-diabetic-retinopathy-compared-to-clinical-examination-7150 https://curecurrent.com/trials/the-role-of-apathy-in-glycemic-control-7151 https://curecurrent.com/trials/inspire-diabetes-study-basal-bolus-insulin-as-primary-treatment-of-type-2-diabetes-7152 https://curecurrent.com/trials/comparison-study-of-lay-person-finger-stick-versus-blood-draw-7153 https://curecurrent.com/trials/aliskiren-trial-in-type-2-diabetes-using-cardiovascular-and-renal-disease-endpoints-core-and-extension-phases-7154 https://curecurrent.com/trials/a-low-carbohydrate-ketogenic-diet-versus-orlistat-for-weight-loss-7155 https://curecurrent.com/trials/strategies-to-maintain-cardiac-risk-control-after-discharge-from-cardiovascular-risk-reduction-clinic-7156 https://curecurrent.com/trials/a-randomized-double-blind-comparator-and-placebo-controlled-multiple-dose-study-to-evaluate-the-safety-tolerability-and-7157 https://curecurrent.com/trials/effectiveness-of-dermapace-device-and-standard-treatment-compared-to-standard-treatment-alone-for-diabetic-foot-ulcers-7158 https://curecurrent.com/trials/efficacy-assessment-of-insulin-glargine-versus-liraglutide-after-oral-agents-failure-7159 https://curecurrent.com/trials/multi-targeted-cardiac-risk-intervention-in-type-2-diabetes-7160 https://curecurrent.com/trials/effect-of-type-2-diabetes-genetic-risk-information-on-health-behaviors-and-outcomes-7161 https://curecurrent.com/trials/grafix-dfu-open-label-extension-option-to-evaluate-safety-efficacy-of-grafix-for-chronic-diabetic-foot-ulcers-7162 https://curecurrent.com/trials/the-effects-of-sevelamer-carbonate-on-diabetic-nephropathy-7163 https://curecurrent.com/trials/lifestyle-change-to-prevent-diabetes-via-african-american-churches-7164 https://curecurrent.com/trials/vitamin-d-and-adipose-tissue-inflammation-7165 https://curecurrent.com/trials/adopting-a-physically-active-lifestyle-through-organized-walk-events-among-joslin-clinic-patients-7166 https://curecurrent.com/trials/effects-of-colesevelam-on-how-the-body-responds-to-insulin-in-patients-with-type-2-diabetes-7167 https://curecurrent.com/trials/multiple-dose-pharmacokinetics-of-canagliflozin-metformin-150-1-000-mg-fixed-dose-combination-7168 https://curecurrent.com/trials/tactics-targeting-adherence-to-cholesterol-lowering-therapy-to-improve-control-study-7169 https://curecurrent.com/trials/comparative-effectiveness-of-bariatric-surgery-versus-medical-management-to-induce-diabetes-remission-in-diabetic-patien-7170 https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-ranolazine-on-postprandial-glucagon-in-subjects-with-type-2-diabetes-7171 https://curecurrent.com/trials/identifying-and-overcoming-barriers-to-diabetes-management-in-the-elderly-a-cost-effective-intervention-study-7172 https://curecurrent.com/trials/identifying-and-overcoming-barriers-to-diabetes-management-in-the-elderly-an-intervention-study-7173 https://curecurrent.com/trials/type-1-diabetes-mellitus-bone-mineral-density-in-childhood-and-adolescence-7174 https://curecurrent.com/trials/linagliptin-versus-placebo-in-type-2-diabetic-patients-with-inadequate-glycaemic-control-on-metformin-in-combination-wit-7175 https://curecurrent.com/trials/maintaining-resistance-training-in-older-prediabetic-adults-7176 https://curecurrent.com/trials/safety-and-efficacy-study-of-insulin-lispro-versus-insulin-aspart-in-participants-with-type-2-diabetes-on-insulin-pump-t-7177 https://curecurrent.com/trials/impact-of-web-based-care-management-for-poorly-controlled-type-2-diabetes-mellitus-a-randomized-controlled-trial-7178 https://curecurrent.com/trials/walnuts-and-glucose-variability-7179 https://curecurrent.com/trials/use-of-integra-flowable-wound-matrix-to-manage-diabetic-foot-ulcers-7180 https://curecurrent.com/trials/outpatient-study-to-evaluate-safety-and-effectiveness-of-the-low-glucose-suspend-feature-7181 https://curecurrent.com/trials/tri-staple-technology-stapler-used-in-gastric-bypass-7182 https://curecurrent.com/trials/efficacy-and-safety-of-3-doses-of-bi1356-linagliptin-in-type-2-diabetes-patients-7183 https://curecurrent.com/trials/janssen-glucose-regulation-risp-olanz-7184 https://curecurrent.com/trials/desensitization-for-highly-sensitized-recipients-of-pancreas-transplantation-7185 https://curecurrent.com/trials/pfizer-ivgtt-ziprasidone-olanzapine-7186 https://curecurrent.com/trials/basal-bolus-insulin-versus-ssri-in-type-2-diabetes-undergoing-general-surgery-7187 https://curecurrent.com/trials/telmisartan-fixed-dose-combination-vs-amlodipine-in-hypertensive-patients-with-type-2-diabetes-mellitus-7188 https://curecurrent.com/trials/sleep-apnea-in-look-ahead-action-for-health-in-diabetes-7189 https://curecurrent.com/trials/a-comparison-of-the-dermapace-pulsed-acoustic-cellular-expression-device-in-conjunction-with-standard-of-care-versus-sta-7190 https://curecurrent.com/trials/a-long-term-safety-study-with-tapentadol-er-and-oxycodone-cr-in-patients-with-moderate-to-severe-pain-due-to-chronic-pai-7191 https://curecurrent.com/trials/welchol-as-monotherapy-for-type-2-diabetes-mellitus-7192 https://curecurrent.com/trials/the-autologel-post-market-surveillance-taps-program-7193 https://curecurrent.com/trials/rilonacept-in-diabetes-mellitus-type-1-safety-study-7194 https://curecurrent.com/trials/phase-2-study-of-adaptive-insulin-meal-supervisor-aims-in-adults-with-type-1-diabetes-mellitus-7195 https://curecurrent.com/trials/efficacy-and-safety-in-patients-with-type-2-diabetes-mellitus-and-cardiovascular-disease-7196 https://curecurrent.com/trials/dipeptidyl-peptidase-4-inhibition-and-immune-function-in-hiv-7197 https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-paz320-in-patients-with-type-2-diabetes-7198 https://curecurrent.com/trials/tolerability-safety-and-efficacy-study-of-ingap-peptide-to-treat-type-1-diabetes-mellitus-in-adults-7199 https://curecurrent.com/trials/insulin-infusion-in-the-hospital-wards-7200 https://curecurrent.com/trials/glyburide-compared-to-insulin-in-the-management-of-white-s-classification-a2-gestational-diabetes-7201 https://curecurrent.com/trials/a-phase-1b-study-of-laps-exendin-in-subjects-of-type-2-diabetes-mellitus-7202 https://curecurrent.com/trials/expanding-comparative-effectiveness-research-cer-capability-through-complex-patient-relationship-management-7203 https://curecurrent.com/trials/u-500r-insulin-in-type-2-diabetes-with-severe-insulin-resistance-via-omnipod-7204 https://curecurrent.com/trials/results-of-tc99m-maraciclatide-scintigraphy-in-subjects-with-diabetes-mellitus-and-heart-failure-with-preserved-left-ven-7205 https://curecurrent.com/trials/randomized-prospective-evaluation-of-the-toad-brace-in-plantar-ulcer-off-loading-and-healing-7206 https://curecurrent.com/trials/the-effect-of-exercise-training-intensity-in-patients-with-type-2-diabetes-7207 https://curecurrent.com/trials/efficacy-and-safety-of-linagliptin-bi-1356-in-black-african-americans-with-type-2-diabetes-with-a-mtt-sub-study-7208 https://curecurrent.com/trials/efficacy-and-safety-of-bi-1356-in-combination-with-metformin-in-patients-with-type-2-diabetes-7209 https://curecurrent.com/trials/dose-ranging-study-of-the-glp-1-agonist-ave0010-in-metformin-treated-subjects-with-type-2-diabetes-mellitus-7210 https://curecurrent.com/trials/efficacy-and-safety-of-b-i1356-linagliptin-vs-placebo-added-to-metformin-background-therapy-in-patients-with-type-2-diab-7211 https://curecurrent.com/trials/evaluation-of-the-effects-of-hp828-101-versus-standard-of-care-in-the-management-of-partial-or-full-thickness-wounds-7212